<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="/global/feed/rss.xslt" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:media="http://search.yahoo.com/mrss/" xmlns:podaccess="https://access.acast.com/schema/1.0/" xmlns:acast="https://schema.acast.com/1.0/">
    <channel>
		<ttl>60</ttl>
		<generator>acast.com</generator>
		<title>Revmatologi</title>
		<link>https://shows.acast.com/revmatologi</link>
		<atom:link href="https://feeds.acast.com/public/shows/630e07bea839d60014dfb735" rel="self" type="application/rss+xml"/>
		<language>nb</language>
		<copyright>Jens Vikse</copyright>
		<itunes:keywords>Revmatologi,inflammasjon,immunologi,artritt,bindevevssykdom,vaskulitt,autoantistoff,antistoff,lupus,leddgikt,systemisk sklerose</itunes:keywords>
		<itunes:author>Jens Vikse</itunes:author>
		<itunes:subtitle>For leger og medisinstudenter</itunes:subtitle>
		<itunes:summary><![CDATA[<p>Av og med revmatolog Jens Vikse.</p><br><p>Har du spørsmål om innholdet i podkasten? <a href="mailto:jensvikse@gmail.com" rel="noopener noreferrer" target="_blank">Send meg en e-post</a>.</p><br><p>Episodetyper:</p><ul><li>Oversiktsepisoder: Jens forklarer tema til en legekollega fra et annet fagfelt. Målgruppe: medisinstudenter, LIS i revmatologi, og leger fra andre fagfelt.</li><li>Ekspertepisoder: Jens intervjuer en ekspert på temaet. Målgruppe: LIS og spesialister i revmatologi.</li></ul><p><br></p><p>Annen info:</p><ul><li>Podkasten er tilleggsmateriale til en <a href="https://www.universitetsforlaget.no/laerebok-i-revmatologi" rel="noopener noreferrer" target="_blank">lærebok i revmatologi</a>.</li><li>Podkasten er finansiert gjennom et stipend fra Norsk revmatologisk forening (NRF). NRF har ingen redaksjonell rolle, og er ikke ansvarlig for innholdet i podkasten.</li><li>Podkasten innhold er ikke ment å erstatte kliniske retningslinjer eller beslutningsstøtteverktøy.</li></ul><p><br></p><p>Programleders disclosures:</p><ul><li>Vikse har mottatt honorar for forelesninger og annet faglig arbeid fra Abbvie, Amgen, Boehringer-Ingelheim, GSK, Janssen, Merck, Novartis, Thermofisher og UCB. Ingen av disse er direkte relatert til podkasten, og firmaene har ingen påvirkning på podkastens innhold</li></ul><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		<description><![CDATA[<p>Av og med revmatolog Jens Vikse.</p><br><p>Har du spørsmål om innholdet i podkasten? <a href="mailto:jensvikse@gmail.com" rel="noopener noreferrer" target="_blank">Send meg en e-post</a>.</p><br><p>Episodetyper:</p><ul><li>Oversiktsepisoder: Jens forklarer tema til en legekollega fra et annet fagfelt. Målgruppe: medisinstudenter, LIS i revmatologi, og leger fra andre fagfelt.</li><li>Ekspertepisoder: Jens intervjuer en ekspert på temaet. Målgruppe: LIS og spesialister i revmatologi.</li></ul><p><br></p><p>Annen info:</p><ul><li>Podkasten er tilleggsmateriale til en <a href="https://www.universitetsforlaget.no/laerebok-i-revmatologi" rel="noopener noreferrer" target="_blank">lærebok i revmatologi</a>.</li><li>Podkasten er finansiert gjennom et stipend fra Norsk revmatologisk forening (NRF). NRF har ingen redaksjonell rolle, og er ikke ansvarlig for innholdet i podkasten.</li><li>Podkasten innhold er ikke ment å erstatte kliniske retningslinjer eller beslutningsstøtteverktøy.</li></ul><p><br></p><p>Programleders disclosures:</p><ul><li>Vikse har mottatt honorar for forelesninger og annet faglig arbeid fra Abbvie, Amgen, Boehringer-Ingelheim, GSK, Janssen, Merck, Novartis, Thermofisher og UCB. Ingen av disse er direkte relatert til podkasten, og firmaene har ingen påvirkning på podkastens innhold</li></ul><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
		<itunes:explicit>false</itunes:explicit>
		<itunes:owner>
			<itunes:name>Jens Vikse</itunes:name>
			<itunes:email>info+630e07bea839d60014dfb735@mg-eu.acast.com</itunes:email>
		</itunes:owner>
		<acast:showId>630e07bea839d60014dfb735</acast:showId>
		<acast:showUrl>revmatologi</acast:showUrl>
		<acast:signature key="EXAMPLE" algorithm="aes-256-cbc"><![CDATA[wbG1Z7+6h9QOi+CR1Dv0uQ==]]></acast:signature>
		<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmTHg2/BXqPr07kkpFZ5JfhvEZqggcpunI6E1w81XpUaBscFc3skEQ0jWG4GCmQYJ66w6pH6P/aGd3DnpJN6h/CD4icd8kZVl4HZn12KicA2k]]></acast:settings>
        <acast:network id="630e07bea839d60014dfb737" slug="jens-vikse"><![CDATA[Jens Vikse]]></acast:network>
		<itunes:type>episodic</itunes:type>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<image>
				<url>https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg</url>
				<link>https://shows.acast.com/revmatologi</link>
				<title>Revmatologi</title>
			</image>
		<item>
			<title>RA-ILD: ekspertepisode - live fra NRFs julekurs (med Natasha Moe, Phuong Phuong Diep og Asad Chaudhary)</title>
			<itunes:title>RA-ILD: ekspertepisode - live fra NRFs julekurs (med Natasha Moe, Phuong Phuong Diep og Asad Chaudhary)</itunes:title>
			<pubDate>Wed, 10 Dec 2025 04:00:00 GMT</pubDate>
			<itunes:duration>28:34</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/6927719830ebd3864873b5c5/media.mp3" length="14199614" type="audio/mpeg"/>
			<guid isPermaLink="false">6927719830ebd3864873b5c5</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/ra-ild-ekspertepisode-live-fra-nrfs-julekurs-med-natasha-moe</link>
			<acast:episodeId>6927719830ebd3864873b5c5</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>ra-ild-ekspertepisode-live-fra-nrfs-julekurs-med-natasha-moe</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5CLqJUjx3IyyNV1CftNFUBt1LcMYIfLIjUHJOfi1P2eJeAbxjA1yEar7fwFvfcl9U2TRS7Q4I/jD9Ppjn/ahwp1]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>3</itunes:season>
			<itunes:episode>66</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#66. Interstitiell lungesykdom (ILD) ved revmatoid artritt (RA) med tre eksperter fra Rikshospitalet: Natasha Moe (toraksradiolog), Phuong Phuong Diep (lungelege) og Asad Chaudhary (revmatolog). Spilt inn live under Norsk revmatologisk forenings julekurs i Drammen, november 2025.</p><br><p>Tredje sesong av podkasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#66. Interstitiell lungesykdom (ILD) ved revmatoid artritt (RA) med tre eksperter fra Rikshospitalet: Natasha Moe (toraksradiolog), Phuong Phuong Diep (lungelege) og Asad Chaudhary (revmatolog). Spilt inn live under Norsk revmatologisk forenings julekurs i Drammen, november 2025.</p><br><p>Tredje sesong av podkasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Nyoppstått artritt del 2: kasuistikker (med Silje Syversen)</title>
			<itunes:title>Nyoppstått artritt del 2: kasuistikker (med Silje Syversen)</itunes:title>
			<pubDate>Thu, 27 Nov 2025 22:22:13 GMT</pubDate>
			<itunes:duration>43:24</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/69276da330ebd3864872d2a5/media.mp3" length="21668205" type="audio/mpeg"/>
			<guid isPermaLink="false">69276da330ebd3864872d2a5</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/nyoppstatt-artritt-del-2-kasuistikker-med-silje-syversen</link>
			<acast:episodeId>69276da330ebd3864872d2a5</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>nyoppstatt-artritt-del-2-kasuistikker-med-silje-syversen</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5Ax5Avj1JTweUcs8FvUidcGb5Dp1CF+pMfIIf7Ko/Jf8uIv1jhR2MKnjw0CnXSwHll4MjZPBYopCs7XBeVI1nD/]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>3</itunes:season>
			<itunes:episode>65</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#65. Ekspertepisode med Silje Syversen, leder av Norsk revmatologisk forening, overlege, seniorforsker og assisterende leder for forskningsenheten ved revmatologisk klinikk, Diakonhjemmet sykehus.</p><br><p>Tredje sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#65. Ekspertepisode med Silje Syversen, leder av Norsk revmatologisk forening, overlege, seniorforsker og assisterende leder for forskningsenheten ved revmatologisk klinikk, Diakonhjemmet sykehus.</p><br><p>Tredje sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Nyoppstått artritt del 1: differensialdiagnostiske overveielser (med Silje Syversen)</title>
			<itunes:title>Nyoppstått artritt del 1: differensialdiagnostiske overveielser (med Silje Syversen)</itunes:title>
			<pubDate>Mon, 27 Oct 2025 14:00:00 GMT</pubDate>
			<itunes:duration>46:37</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/68fefd56deee754a72d2a0ee/media.mp3" length="23275753" type="audio/mpeg"/>
			<guid isPermaLink="false">68fefd56deee754a72d2a0ee</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/nyoppstatt-artritt-del-1-differensialdiagnostiske-overveiels</link>
			<acast:episodeId>68fefd56deee754a72d2a0ee</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>nyoppstatt-artritt-del-1-differensialdiagnostiske-overveiels</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5B05yTZjSj6WSC/8Vv6D2onPrlQ2e03cXrLXhKsnYrsCpQm6NEZzRs/lIcwPd4aiMXvFxjF9nx4fVpwqYdK4pZp]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>3</itunes:season>
			<itunes:episode>64</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#64. Ekspertepisode med Silje Syversen, leder av Norsk revmatologisk forening, overlege, seniorforsker og assisterende leder for forskningsenheten ved revmatologisk klinikk, Diakonhjemmet sykehus.</p><br><p>Tredje sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#64. Ekspertepisode med Silje Syversen, leder av Norsk revmatologisk forening, overlege, seniorforsker og assisterende leder for forskningsenheten ved revmatologisk klinikk, Diakonhjemmet sykehus.</p><br><p>Tredje sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>B-cellerettet behandling del 2: andre medikamenter mot CD19 og CD20 (CAR-T, BiTE, yd T-celler, ADC)</title>
			<itunes:title>B-cellerettet behandling del 2: andre medikamenter mot CD19 og CD20 (CAR-T, BiTE, yd T-celler, ADC)</itunes:title>
			<pubDate>Mon, 15 Sep 2025 05:01:28 GMT</pubDate>
			<itunes:duration>38:12</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/68bf2f51b494ca82a29774ae/media.mp3" length="19031890" type="audio/mpeg"/>
			<guid isPermaLink="false">68bf2f51b494ca82a29774ae</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/b-cellerettet-behandling-del-1-andre-medikamenter-mot-cd19-o</link>
			<acast:episodeId>68bf2f51b494ca82a29774ae</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>b-cellerettet-behandling-del-1-andre-medikamenter-mot-cd19-o</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5BeZfIiO339qouU6RSUQi6b5edgFM9Qn7MIhUHMB8G+K61iG080mIf+PODZOx9r6zZwRw75L9HQfALpPqxKD2Vq]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>3</itunes:season>
			<itunes:episode>63</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#63. Medikamenter/prinsipper som nevnes: autolog CD19 CAR-T, allogen CD19 CAR-T, in vivo CD19 CAR-T, CD19 CAR-NK, blinatumomab, gamma delta T-celler, ACE1831, lonkastuksimab tesirin.</p><br><p>Utvalgt litteratur (omtalt i episoden): <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2308917" rel="noopener noreferrer" target="_blank">Müller et al 2024</a> (kasuistikker fra Erlangen: CAR-T i revmatologien), <a href="https://pubmed.ncbi.nlm.nih.gov/39107407/" rel="noopener noreferrer" target="_blank">Schett et al 2024</a> (review: CAR-T i revmatologien) <a href="https://pubmed.ncbi.nlm.nih.gov/39700499/" rel="noopener noreferrer" target="_blank">Mougiakakos et al 2025</a> (review: CAR-T i revmatologien), <a href="https://pubmed.ncbi.nlm.nih.gov/38135464/" rel="noopener noreferrer" target="_blank">Merkt et al 2024</a> (kasuistikk: tredjegenerasjons CAR-T i SSc), <a href="https://pubmed.ncbi.nlm.nih.gov/37055515/" rel="noopener noreferrer" target="_blank">Cappell et al 2023</a> (review: langtidsutfall av CAR-T for kreft) <a href="https://pubmed.ncbi.nlm.nih.gov/37835538/" rel="noopener noreferrer" target="_blank">Li et al 2023</a> (ACE1831).</p><br><p>Tredje sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#63. Medikamenter/prinsipper som nevnes: autolog CD19 CAR-T, allogen CD19 CAR-T, in vivo CD19 CAR-T, CD19 CAR-NK, blinatumomab, gamma delta T-celler, ACE1831, lonkastuksimab tesirin.</p><br><p>Utvalgt litteratur (omtalt i episoden): <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2308917" rel="noopener noreferrer" target="_blank">Müller et al 2024</a> (kasuistikker fra Erlangen: CAR-T i revmatologien), <a href="https://pubmed.ncbi.nlm.nih.gov/39107407/" rel="noopener noreferrer" target="_blank">Schett et al 2024</a> (review: CAR-T i revmatologien) <a href="https://pubmed.ncbi.nlm.nih.gov/39700499/" rel="noopener noreferrer" target="_blank">Mougiakakos et al 2025</a> (review: CAR-T i revmatologien), <a href="https://pubmed.ncbi.nlm.nih.gov/38135464/" rel="noopener noreferrer" target="_blank">Merkt et al 2024</a> (kasuistikk: tredjegenerasjons CAR-T i SSc), <a href="https://pubmed.ncbi.nlm.nih.gov/37055515/" rel="noopener noreferrer" target="_blank">Cappell et al 2023</a> (review: langtidsutfall av CAR-T for kreft) <a href="https://pubmed.ncbi.nlm.nih.gov/37835538/" rel="noopener noreferrer" target="_blank">Li et al 2023</a> (ACE1831).</p><br><p>Tredje sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>B-cellerettet behandling del 1: monoklonale antistoffer mot CD19 og CD20</title>
			<itunes:title>B-cellerettet behandling del 1: monoklonale antistoffer mot CD19 og CD20</itunes:title>
			<pubDate>Tue, 09 Sep 2025 07:46:33 GMT</pubDate>
			<itunes:duration>32:51</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/68bedee4d39b041a4721fd72/media.mp3" length="16369840" type="audio/mpeg"/>
			<guid isPermaLink="false">68bedee4d39b041a4721fd72</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/b-cellerettet-behandling-del-1-monoklonale-antistoff-mot-cd1</link>
			<acast:episodeId>68bedee4d39b041a4721fd72</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>b-cellerettet-behandling-del-1-monoklonale-antistoff-mot-cd1</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5BXwG/cbIR+NRNSRnrTtb8M9zG2DoqPadpAG8p94kZJMYdXsj4gM9oZfYizYYkxexT2UAVh4vg2SN6F04DzZi0q]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>3</itunes:season>
			<itunes:episode>62</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#62. Medikamenter som nevnes: rituksimab, okrelizumab, ofatumumab, tositumomab, obinutuzumab, inebilizumab, obekselimab.</p><br><p>Utvalgte referanser: <a href="https://pubmed.ncbi.nlm.nih.gov/39815102/" rel="noopener noreferrer" target="_blank">Stockfelt et al 2025</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/38777374/" rel="noopener noreferrer" target="_blank">Schett et al 2024</a>.</p><br><p>Tredje sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#62. Medikamenter som nevnes: rituksimab, okrelizumab, ofatumumab, tositumomab, obinutuzumab, inebilizumab, obekselimab.</p><br><p>Utvalgte referanser: <a href="https://pubmed.ncbi.nlm.nih.gov/39815102/" rel="noopener noreferrer" target="_blank">Stockfelt et al 2025</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/38777374/" rel="noopener noreferrer" target="_blank">Schett et al 2024</a>.</p><br><p>Tredje sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Hvasadumab? - Forstå hvorfor monoklonale antistoffer heter det de gjør</title>
			<itunes:title>Hvasadumab? - Forstå hvorfor monoklonale antistoffer heter det de gjør</itunes:title>
			<pubDate>Mon, 04 Aug 2025 00:00:00 GMT</pubDate>
			<itunes:duration>34:58</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/688fd1d2f3a75290d4680dde/media.mp3" length="17430264" type="audio/mpeg"/>
			<guid isPermaLink="false">688fd1d2f3a75290d4680dde</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/hvasadumab-forsta-hvorfor-monoklonale-antistoffer-heter-det</link>
			<acast:episodeId>688fd1d2f3a75290d4680dde</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>hvasadumab-forsta-hvorfor-monoklonale-antistoffer-heter-det</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5DKDtdJUx5e+uxVjtVCz9YSReFTh0phtHjzvHRts92vw58CojK5iIqpU4XXdoajGf+M4IzBL7J60fI1zllwP+J+]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>3</itunes:season>
			<itunes:episode>61</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[#61. Monoklonale antistoffer (som adalimumab, infliksimab, rituksimab, og tocilizumab) navngis etter WHOs "international nonproprietary naming (INN) scheme for monoclonal antibodies". Lær om tidligere og nyeste INN-system, og forstå hvor de kompliserte navnene kommer fra.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[#61. Monoklonale antistoffer (som adalimumab, infliksimab, rituksimab, og tocilizumab) navngis etter WHOs "international nonproprietary naming (INN) scheme for monoclonal antibodies". Lær om tidligere og nyeste INN-system, og forstå hvor de kompliserte navnene kommer fra.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>B-celler del 6: ekstrafollikulær reaksjon, plasmablaster, plasmaceller, DN2 B-celler</title>
			<itunes:title>B-celler del 6: ekstrafollikulær reaksjon, plasmablaster, plasmaceller, DN2 B-celler</itunes:title>
			<pubDate>Mon, 07 Jul 2025 03:00:00 GMT</pubDate>
			<itunes:duration>14:18</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/6863db1acc507bdab61e8beb/media.mp3" length="7117208" type="audio/mpeg"/>
			<guid isPermaLink="false">6863db1acc507bdab61e8beb</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/b-celler-del-6-ekstrafollikulaer-reaksjon-plasmablaster-plas</link>
			<acast:episodeId>6863db1acc507bdab61e8beb</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>b-celler-del-6-ekstrafollikulaer-reaksjon-plasmablaster-plas</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5C8/9ulBx6Dy+bwxQVmK1fgwel/o0OahadPt7sj9LCeLiY2hCjyeYvEM7eVoOQXpSUKXIpxdRVP8dNgNfc/99Li]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>3</itunes:season>
			<itunes:episode>60</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#60. Ting som nevnes: ekstrafollikulær reaksjon (extrafollicular reaction), plasmablaster, kortlivede plasmaceller, langlivede plasmaceller, B-hukommelsesceller, dobbelt negative (DN) B-celler, herunder DN B-celle subtype 2 (DN2 B-celler).</p><br><p>Sesong 3 er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#60. Ting som nevnes: ekstrafollikulær reaksjon (extrafollicular reaction), plasmablaster, kortlivede plasmaceller, langlivede plasmaceller, B-hukommelsesceller, dobbelt negative (DN) B-celler, herunder DN B-celle subtype 2 (DN2 B-celler).</p><br><p>Sesong 3 er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>B-celler del 5: kimsenterreaksjon</title>
			<itunes:title>B-celler del 5: kimsenterreaksjon</itunes:title>
			<pubDate>Tue, 01 Jul 2025 20:00:00 GMT</pubDate>
			<itunes:duration>20:22</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/6863d1bdd9fe1412182620e6/media.mp3" length="10129480" type="audio/mpeg"/>
			<guid isPermaLink="false">6863d1bdd9fe1412182620e6</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/b-celler-del-5-kimsenterreaksjon</link>
			<acast:episodeId>6863d1bdd9fe1412182620e6</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>b-celler-del-5-kimsenterreaksjon</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5AT/1cmqZMBtlPRKxje0qnhDl8glV6pHBiBrbJ8SKpLuwGjMKBi4F2jOu0Ax4PJzUPkMR4YMDBPWNpHmRxEVEBI]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>3</itunes:season>
			<itunes:episode>59</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#59. Ting som nevnes: kimsenterreaksjon (germinal center reaction), ekstrafollikulær reaksjon (extrafollicular reaction), kostimulering, somatisk hypermutasjon, aktiveringsindusert deaminase, klasseskifte, CD27, CD38, CD138, TACI, BCMA.</p><br><p>Tredje sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#59. Ting som nevnes: kimsenterreaksjon (germinal center reaction), ekstrafollikulær reaksjon (extrafollicular reaction), kostimulering, somatisk hypermutasjon, aktiveringsindusert deaminase, klasseskifte, CD27, CD38, CD138, TACI, BCMA.</p><br><p>Tredje sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>B-celler del 4: overflateproteiner</title>
			<itunes:title>B-celler del 4: overflateproteiner</itunes:title>
			<pubDate>Sun, 15 Jun 2025 06:00:00 GMT</pubDate>
			<itunes:duration>24:34</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/6849e0ef1a37473f7d14f853/media.mp3" length="12203453" type="audio/mpeg"/>
			<guid isPermaLink="false">6849e0ef1a37473f7d14f853</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/b-celler-del-4-overflateproteiner</link>
			<acast:episodeId>6849e0ef1a37473f7d14f853</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>b-celler-del-4-overflateproteiner</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5AbeizZbkPlEkszVxS+OibkfWU1qqrxOpmRQUdoYX7Wvz1fRTPuSaL1EMGRiJwQDXO2Zaf0LjXydb8kmQJzffSh]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>3</itunes:season>
			<itunes:episode>58</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#58. Ting som nevnes: CD19, CD20, CD21, CD22, CD40, BAFF, BAFF-R, TACI, BCMA, BTK, FcyRIIb.</p><br><p>Tredje sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#58. Ting som nevnes: CD19, CD20, CD21, CD22, CD40, BAFF, BAFF-R, TACI, BCMA, BTK, FcyRIIb.</p><br><p>Tredje sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>B-celler del 3: reseptorproduksjon, klasseskifte</title>
			<itunes:title>B-celler del 3: reseptorproduksjon, klasseskifte</itunes:title>
			<pubDate>Mon, 09 Jun 2025 21:52:11 GMT</pubDate>
			<itunes:duration>25:33</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/6845e3a0a13d3373731f7ef4/media.mp3" length="12699933" type="audio/mpeg"/>
			<guid isPermaLink="false">6845e3a0a13d3373731f7ef4</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/b-celler-del-3-modning-og-produksjon-av-b-cellereseptorer</link>
			<acast:episodeId>6845e3a0a13d3373731f7ef4</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>b-celler-del-3-modning-og-produksjon-av-b-cellereseptorer</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5DmuPr4HburliERLE5VXyP18qn+sTS9lljWeIFK0Dj7jRz+u7GEJXmfFLHAzQcciTEY4rGXwtXX/pjBLRjryT85]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>3</itunes:season>
			<itunes:episode>57</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#57. Ting som nevnes: Fab-regioner (armene, som utgjøres av V-, D- og J-segmenter), Fc-regioner (benet, som utgjøres av C-segmenter). Fc-reseptorer (FcR). Klasseskifte.</p><br><p>Tredje sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#57. Ting som nevnes: Fab-regioner (armene, som utgjøres av V-, D- og J-segmenter), Fc-regioner (benet, som utgjøres av C-segmenter). Fc-reseptorer (FcR). Klasseskifte.</p><br><p>Tredje sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>B-celler del 2: aktivering, effektorceller, antistoffer</title>
			<itunes:title>B-celler del 2: aktivering, effektorceller, antistoffer</itunes:title>
			<pubDate>Sat, 31 May 2025 01:00:00 GMT</pubDate>
			<itunes:duration>24:25</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/683a31945b56407fa4219688/media.mp3" length="12156418" type="audio/mpeg"/>
			<guid isPermaLink="false">683a31945b56407fa4219688</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/b-celler-del-2-aktivering-effektorceller-antistoffer</link>
			<acast:episodeId>683a31945b56407fa4219688</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>b-celler-del-2-aktivering-effektorceller-antistoffer</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5CWsrxA7+9nHwAsXA5vhm0ov8zNMnY6n9wLK/65tW/NQziveVCsGKRNiaw5qEcEH7dWa3WxKc5RayRx+XfQyuv2]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>3</itunes:season>
			<itunes:episode>56</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#56. Ting som nevnes i denne episoden: aktivering av T- og B-celler. Effektorceller versus hukommelsesceller. Th1 vs Th2 vs Th17 vs. follikulære T-hjelpeceller. CD40 og CD40 ligand (CD40L). Antistoffproduserende celler (plasmablaster og plasmaceller). Opsonisering. Antistoffavhengig cellemediert cytotoksisitet (ADCC). Komplementmediert cytotoksisitet (CDC).</p><br><p>Tredje sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#56. Ting som nevnes i denne episoden: aktivering av T- og B-celler. Effektorceller versus hukommelsesceller. Th1 vs Th2 vs Th17 vs. follikulære T-hjelpeceller. CD40 og CD40 ligand (CD40L). Antistoffproduserende celler (plasmablaster og plasmaceller). Opsonisering. Antistoffavhengig cellemediert cytotoksisitet (ADCC). Komplementmediert cytotoksisitet (CDC).</p><br><p>Tredje sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>B-celler del 1: reseptorer, spesifisitet, sirkulering</title>
			<itunes:title>B-celler del 1: reseptorer, spesifisitet, sirkulering</itunes:title>
			<pubDate>Fri, 30 May 2025 22:27:43 GMT</pubDate>
			<itunes:duration>24:57</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/683a30df2780b226c7b2fe1f/media.mp3" length="12416560" type="audio/mpeg"/>
			<guid isPermaLink="false">683a30df2780b226c7b2fe1f</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/b-celler-del-1-reseptorer-spesifisitet-sirkulering</link>
			<acast:episodeId>683a30df2780b226c7b2fe1f</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>b-celler-del-1-reseptorer-spesifisitet-sirkulering</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5Dmbm6/NXN/S2QJRgqEtx28gy9VqriCdmAnkAoTsnu0i9LfV0A/ud2+kBao0RU7g+KBPlq9BgB8pmc7SCobmrit]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>3</itunes:season>
			<itunes:episode>55</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#55. En serie om B-celler! Ting som nevnes i denne første episoden: PRR, PAMPer, DAMPer, BCR, TCR, V(D)J-rearrangering, primære og sekundære lymfoide organer</p><br><p>Tredje sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#55. En serie om B-celler! Ting som nevnes i denne første episoden: PRR, PAMPer, DAMPer, BCR, TCR, V(D)J-rearrangering, primære og sekundære lymfoide organer</p><br><p>Tredje sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Behcet del 4: live ekspertepisode med Aksel Thuv Nilsen</title>
			<itunes:title>Behcet del 4: live ekspertepisode med Aksel Thuv Nilsen</itunes:title>
			<pubDate>Mon, 07 Apr 2025 03:00:00 GMT</pubDate>
			<itunes:duration>41:47</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/67e9b14ce270d6e036052e4a/media.mp3" length="20839736" type="audio/mpeg"/>
			<guid isPermaLink="false">67e9b14ce270d6e036052e4a</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/behcet-del-4-live-ekspertepisode-med-aksel-thuv-nilsen</link>
			<acast:episodeId>67e9b14ce270d6e036052e4a</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>behcet-del-4-live-ekspertepisode-med-aksel-thuv-nilsen</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5B5cjOSqvIwoD3YO/hwBV466l9gja4J/BAiOGOem5/FJevJERKTmAcjovu/fHvV0Nh0peYK9bswF06C0C8hksfj]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>3</itunes:season>
			<itunes:episode>54</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#54. Live fra NRFs julekurs i 2024. Aksel Thuv Nilsen får presentert følgende diagnostiske utfordring: en etnisk norsk kvinne med orogenitale sår. Har hun Behcet?</p><br><p>Tredje sesong av podkasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#54. Live fra NRFs julekurs i 2024. Aksel Thuv Nilsen får presentert følgende diagnostiske utfordring: en etnisk norsk kvinne med orogenitale sår. Har hun Behcet?</p><br><p>Tredje sesong av podkasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Behcet del 3: diagnostikk og behandling</title>
			<itunes:title>Behcet del 3: diagnostikk og behandling</itunes:title>
			<pubDate>Wed, 02 Apr 2025 05:55:00 GMT</pubDate>
			<itunes:duration>26:58</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/67e9b998f6fbf271934c8ee1/media.mp3" length="13409691" type="audio/mpeg"/>
			<guid isPermaLink="false">67e9b998f6fbf271934c8ee1</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/behcet-del-3-diagnostikk-og-behandling</link>
			<acast:episodeId>67e9b998f6fbf271934c8ee1</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>behcet-del-3-diagnostikk-og-behandling</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5A9cscx6uJ//hGbTKRAXlqQrOATYD2J3zRG3RwMJOZE66ZLZbQbfTZq66P4xNTniJYb0PjOwCYZoG+Ozs7uzkdG]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>3</itunes:season>
			<itunes:episode>53</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#53. Oversiktsepisode. Differensialdiagnoser, diagnostikk, behandling. For detaljert informasjon om behandling av Behcet, se <a href="https://ard.bmj.com/content/77/6/808" rel="noopener noreferrer" target="_blank">EULARs anbefalinger</a>.</p><br><p>Tredje episode av podkasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening. </p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#53. Oversiktsepisode. Differensialdiagnoser, diagnostikk, behandling. For detaljert informasjon om behandling av Behcet, se <a href="https://ard.bmj.com/content/77/6/808" rel="noopener noreferrer" target="_blank">EULARs anbefalinger</a>.</p><br><p>Tredje episode av podkasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening. </p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Behcet del 2b: patofysiologi og MHC I-opatier</title>
			<itunes:title>Behcet del 2b: patofysiologi og MHC I-opatier</itunes:title>
			<pubDate>Thu, 27 Mar 2025 22:00:00 GMT</pubDate>
			<itunes:duration>15:58</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/67ddd91f51430250f51147df/media.mp3" length="7929630" type="audio/mpeg"/>
			<guid isPermaLink="false">67ddd91f51430250f51147df</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/behcet-del-2b-patofysiologi-og-mhc-i-opatier</link>
			<acast:episodeId>67ddd91f51430250f51147df</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>behcet-del-2b-patofysiologi-og-mhc-i-opatier</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5B6MhXaUQii8Sxgu20Zqil2jGIsB1TQwVvez1ScLTOkFJ8qHYNI9vcV5j76uK93EdFAfvgZoowuzWKwauudPHjx]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>3</itunes:season>
			<itunes:episode>52</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#52. Oversiktsepisode.</p><br><p>Tredje sesong av podkasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#52. Oversiktsepisode.</p><br><p>Tredje sesong av podkasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Behcet del 2a: fenotyper, endotyper, nosologi - og litt om nær utsikt</title>
			<itunes:title>Behcet del 2a: fenotyper, endotyper, nosologi - og litt om nær utsikt</itunes:title>
			<pubDate>Mon, 24 Mar 2025 22:55:00 GMT</pubDate>
			<itunes:duration>20:59</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/67ddc29f77bf8b899e7949ae/media.mp3" length="10428836" type="audio/mpeg"/>
			<guid isPermaLink="false">67ddc29f77bf8b899e7949ae</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/behcet-del-2a-fenotyper-endotyper-nosologi</link>
			<acast:episodeId>67ddc29f77bf8b899e7949ae</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>behcet-del-2a-fenotyper-endotyper-nosologi</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5BH2blrrGweBGS59RX6sggW6t5IIHoNfBWC6g9Tb51td9sqePiHkVSgkg1uPmA26Ow+xLvEtf8aw7cucNynhSlZ]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>3</itunes:season>
			<itunes:episode>51</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#51. En litt teknisk (og kanskje noe svevende) bonusepisode i podkast-tetralogien om Behcet.</p><br><p>Tredje sesong av podkasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#51. En litt teknisk (og kanskje noe svevende) bonusepisode i podkast-tetralogien om Behcet.</p><br><p>Tredje sesong av podkasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Behcet del 1: epidemiologi og manifestasjoner</title>
			<itunes:title>Behcet del 1: epidemiologi og manifestasjoner</itunes:title>
			<pubDate>Thu, 20 Mar 2025 22:30:00 GMT</pubDate>
			<itunes:duration>38:19</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/67dc22d92b3a46d7353c6841/media.mp3" length="19049118" type="audio/mpeg"/>
			<guid isPermaLink="false">67dc22d92b3a46d7353c6841</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/behcet-del-1-epidemiologi-og-manifestasjoner</link>
			<acast:episodeId>67dc22d92b3a46d7353c6841</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>behcet-del-1-epidemiologi-og-manifestasjoner</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5AnBiAYiF0VuLsa3388e4SV8PU7T6MV2B6CY9QAmAQHN+E9n1zMoG+0bP4v5sFTx3ouKFJgiuAnF8b37SkTyxTM]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>3</itunes:season>
			<itunes:episode>50</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#50. Runder 50 episoder med den første av flere episoder om Behcet. Denne første er en oversiktsepisode om epidemiologi, symptomer og funn.</p><br><p>Lenker til nevnte oversiktsartikler om Behcet: (1) <a href="https://www.nature.com/articles/s41572-021-00301-1" rel="noopener noreferrer" target="_blank">Yazici Y et al 2021</a>, (2) <a href="https://www.nature.com/articles/nrrheum.2017.208" rel="noopener noreferrer" target="_blank">Yazici H et al 2018</a>, (3) <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02629-6/abstract" rel="noopener noreferrer" target="_blank">Emmi G et al 2024</a>, (4) <a href="https://www.nejm.org/doi/full/10.1056/NEJMra2305712" rel="noopener noreferrer" target="_blank">Saadoun D et al 2024</a>.</p><br><p>Tredje sesong av podkasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#50. Runder 50 episoder med den første av flere episoder om Behcet. Denne første er en oversiktsepisode om epidemiologi, symptomer og funn.</p><br><p>Lenker til nevnte oversiktsartikler om Behcet: (1) <a href="https://www.nature.com/articles/s41572-021-00301-1" rel="noopener noreferrer" target="_blank">Yazici Y et al 2021</a>, (2) <a href="https://www.nature.com/articles/nrrheum.2017.208" rel="noopener noreferrer" target="_blank">Yazici H et al 2018</a>, (3) <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02629-6/abstract" rel="noopener noreferrer" target="_blank">Emmi G et al 2024</a>, (4) <a href="https://www.nejm.org/doi/full/10.1056/NEJMra2305712" rel="noopener noreferrer" target="_blank">Saadoun D et al 2024</a>.</p><br><p>Tredje sesong av podkasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Revmatisk eller revmatologisk sykdom?</title>
			<itunes:title>Revmatisk eller revmatologisk sykdom?</itunes:title>
			<pubDate>Mon, 10 Mar 2025 06:00:00 GMT</pubDate>
			<itunes:duration>6:38</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/67c05fd664dd90753789b8fe/media.mp3" length="3304185" type="audio/mpeg"/>
			<guid isPermaLink="false">67c05fd664dd90753789b8fe</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/revmatisk-eller-revmatologisk-sykdom</link>
			<acast:episodeId>67c05fd664dd90753789b8fe</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>revmatisk-eller-revmatologisk-sykdom</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5Dzd+4lKkkesVH+BDgp286QQ0yABlpVOAVWXgYz77BzvwXfmqyMVEx6xHaoLWtYSGXsXF7796t4FUb7La1FFZiU]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>3</itunes:season>
			<itunes:episode>49</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#49. Bonusepisode som omhandler et <a href="https://tidsskriftet.no/2024/10/sprakspalten/revmatisk-eller-revmatologisk-sykdom" rel="noopener noreferrer" target="_blank">innlegg i Tidsskriftets språkspalte</a>. Takk til Erlend Hem, Petter Gjersvik og Språkrådet for hjelp til arbeidet med innlegget.</p><br><p>Tredje sesong av podkasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#49. Bonusepisode som omhandler et <a href="https://tidsskriftet.no/2024/10/sprakspalten/revmatisk-eller-revmatologisk-sykdom" rel="noopener noreferrer" target="_blank">innlegg i Tidsskriftets språkspalte</a>. Takk til Erlend Hem, Petter Gjersvik og Språkrådet for hjelp til arbeidet med innlegget.</p><br><p>Tredje sesong av podkasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Øyet og revma del 2: skleritt, episkleritt, keratitt, retinal vaskulitt, orbital inflammasjon</title>
			<itunes:title>Øyet og revma del 2: skleritt, episkleritt, keratitt, retinal vaskulitt, orbital inflammasjon</itunes:title>
			<pubDate>Thu, 27 Feb 2025 15:40:00 GMT</pubDate>
			<itunes:duration>17:59</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/67c076aa6b976c3351741537/media.mp3" length="8951107" type="audio/mpeg"/>
			<guid isPermaLink="false">67c076aa6b976c3351741537</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/yet-og-revma-del-2-skleritt-episkleritt-keratitt-retina-vask</link>
			<acast:episodeId>67c076aa6b976c3351741537</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>yet-og-revma-del-2-skleritt-episkleritt-keratitt-retina-vask</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5ASKkXLAjuQo3bC4EVBvnxOjpG98fhvBleKekxYLdkFAwCexKvNLcNWiQL4kjAxW691nvLHi7VMuiWboUPoLAs3]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>3</itunes:season>
			<itunes:episode>48</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#48. Oversiktsepisode om øyemanifestasjoner ved revmatisk sykdom. Del 2 av 2.</p><br><p>Tredje sesong av podkasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><p><br></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#48. Oversiktsepisode om øyemanifestasjoner ved revmatisk sykdom. Del 2 av 2.</p><br><p>Tredje sesong av podkasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><p><br></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Øyet og revma del 1: anatomi og uveitt</title>
			<itunes:title>Øyet og revma del 1: anatomi og uveitt</itunes:title>
			<pubDate>Thu, 27 Feb 2025 15:05:00 GMT</pubDate>
			<itunes:duration>30:30</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/67c075b86b976c335173d6fc/media.mp3" length="15179597" type="audio/mpeg"/>
			<guid isPermaLink="false">67c075b86b976c335173d6fc</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/yet-og-revma-del-1-anatomi-og-uvett</link>
			<acast:episodeId>67c075b86b976c335173d6fc</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>yet-og-revma-del-1-anatomi-og-uvett</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5CUUf/ma/mIJ8omU/RiX14Jyji4lSlEJAOkjRcDK0abXLuie3XvjsOYFJTQbamn8O8njZVuFmruOPI8QtNtJmiZ]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>3</itunes:season>
			<itunes:episode>47</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#47. Oversiktsepisode om øyemanifestasjoner ved revmatisk sykdom. Del 1 av 2.</p><br><p>Tredje sesong av podkasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><br><p>Tusen takk til Norsk revmatologisk forening for the continued support!</p><p><br></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#47. Oversiktsepisode om øyemanifestasjoner ved revmatisk sykdom. Del 1 av 2.</p><br><p>Tredje sesong av podkasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><br><p>Tusen takk til Norsk revmatologisk forening for the continued support!</p><p><br></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>En kvinne i 60-årene med fatigue og alvorlig nyresvikt</title>
			<itunes:title>En kvinne i 60-årene med fatigue og alvorlig nyresvikt</itunes:title>
			<pubDate>Tue, 28 Jan 2025 22:36:45 GMT</pubDate>
			<itunes:duration>37:57</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/67995590a234f420da52b600/media.mp3" length="18946455" type="audio/mpeg"/>
			<guid isPermaLink="false">67995590a234f420da52b600</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/en-kvinne-i-60-arene-med-fatigue-og-alvorlig-nyresvikt</link>
			<acast:episodeId>67995590a234f420da52b600</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>en-kvinne-i-60-arene-med-fatigue-og-alvorlig-nyresvikt</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5AUSVAzhePt7+alqVyC2eERElX1YtL1tnxrK+x2mWrxsNX2Gh/pJePkbZrzz4OnbIWS5s6sBr5GnYGVX1I8igBE]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>3</itunes:season>
			<itunes:episode>46</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[#46. Sesongåpning med kasuistikk.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[#46. Sesongåpning med kasuistikk.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Revmabok.no + feil i figur 30.1</title>
			<itunes:title>Revmabok.no + feil i figur 30.1</itunes:title>
			<pubDate>Tue, 17 Dec 2024 23:12:34 GMT</pubDate>
			<itunes:duration>4:42</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/6761c4736ba7599e64351596/media.mp3" length="2347539" type="audio/mpeg"/>
			<guid isPermaLink="false">6761c4736ba7599e64351596</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/revmabokno-feil-i-figur-301</link>
			<acast:episodeId>6761c4736ba7599e64351596</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>revmabokno-feil-i-figur-301</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5DyJkTZhJal+vSxjH+45SRr5NHtNcy9tz7tAODju+U0lRoyEBo9DpvuTUvoGDJrL1b7vBOveu3PVU8ILVH0e41f]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>2</itunes:season>
			<itunes:episode>45</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>Lærebokens nettside: revmabok.no. Her finnes bilder, videoer, ordbok og quiz.</p><br><p>Det er beklageligvis en feil i figur 30.1 i boken. Omtalt i episoden. Korrekt versjon finnes under "Rettelser" på revmabok.no.</p><p><br></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Lærebokens nettside: revmabok.no. Her finnes bilder, videoer, ordbok og quiz.</p><br><p>Det er beklageligvis en feil i figur 30.1 i boken. Omtalt i episoden. Korrekt versjon finnes under "Rettelser" på revmabok.no.</p><p><br></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Lærebok i revmatologi + tredje podcastsesong</title>
			<itunes:title>Lærebok i revmatologi + tredje podcastsesong</itunes:title>
			<pubDate>Thu, 29 Aug 2024 03:31:43 GMT</pubDate>
			<itunes:duration>4:48</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/66cf95b19ae927bee938607a/media.mp3" length="2398320" type="audio/mpeg"/>
			<guid isPermaLink="false">66cf95b19ae927bee938607a</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/laerebok-i-revmatologi-tredje-podcastsesong</link>
			<acast:episodeId>66cf95b19ae927bee938607a</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>laerebok-i-revmatologi-tredje-podcastsesong</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5CFUkcb/eLbf15l1Dm6GYvcmHv2XL9XpgG/PCR0N7YUD5Kj6QT+O2IqS6C9bKCzThkRhh0Icmz7rRpInkbAlnx5]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>2</itunes:season>
			<itunes:episode>44</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#44. Bonusepisode. Læreboken er lansert. I tillegg info om tredje sesong av podcasten.</p><br><p>Tusen takk til alle som har bidratt til læreboken, og til alle som hører på podcasten.</p><br><p><a href="https://www.universitetsforlaget.no/laerebok-i-revmatologi" rel="noopener noreferrer" target="_blank">Trykk her for mer informasjon om læreboken.</a></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#44. Bonusepisode. Læreboken er lansert. I tillegg info om tredje sesong av podcasten.</p><br><p>Tusen takk til alle som har bidratt til læreboken, og til alle som hører på podcasten.</p><br><p><a href="https://www.universitetsforlaget.no/laerebok-i-revmatologi" rel="noopener noreferrer" target="_blank">Trykk her for mer informasjon om læreboken.</a></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>ANCA-assosiert vaskulitt del 1: GPA og MPA</title>
			<itunes:title>ANCA-assosiert vaskulitt del 1: GPA og MPA</itunes:title>
			<pubDate>Tue, 23 Jul 2024 21:02:31 GMT</pubDate>
			<itunes:duration>38:08</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/669ff75a993be95c7f862bf1/media.mp3" length="18978211" type="audio/mpeg"/>
			<guid isPermaLink="false">669ff75a993be95c7f862bf1</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/anca-assosiert-vaskulitt-del-1-gpa-og-mpa</link>
			<acast:episodeId>669ff75a993be95c7f862bf1</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>anca-assosiert-vaskulitt-del-1-gpa-og-mpa</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5A4P1BgkduGt/uGB5udyid392WqwGCB59nGMJbBEtd7RF0DS8zYaJBZuwJAzMVgWqkg17dC0JAUdZhg7Fi8XKp2]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>2</itunes:season>
			<itunes:episode>43</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#43. Oversiktsepisode. Granulomatose med polyangiitt (GPA) og mikroskopisk polyangiitt (MPA). Eosinofil granulomatose med polyangiitt (EGPA) omtales i en senere episode.</p><br><p>Andre sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#43. Oversiktsepisode. Granulomatose med polyangiitt (GPA) og mikroskopisk polyangiitt (MPA). Eosinofil granulomatose med polyangiitt (EGPA) omtales i en senere episode.</p><br><p>Andre sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Vaskulittsykdommer: inndeling og kjennetegn</title>
			<itunes:title>Vaskulittsykdommer: inndeling og kjennetegn</itunes:title>
			<pubDate>Sun, 30 Jun 2024 20:43:11 GMT</pubDate>
			<itunes:duration>40:03</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/6681b233a2d4e67a7baf7353/media.mp3" length="19952623" type="audio/mpeg"/>
			<guid isPermaLink="false">6681b233a2d4e67a7baf7353</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/vaskulittsykdommer-inndeling-og-kjennetegn</link>
			<acast:episodeId>6681b233a2d4e67a7baf7353</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>vaskulittsykdommer-inndeling-og-kjennetegn</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5AbBnxjiWI+eLM01/3Ivn97r95sZClD/oeIavsYhvSegiN53n4j+9595zOBowXdDg6huGDtJccHO32JgV9EN9yv]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>2</itunes:season>
			<itunes:episode>42</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#42. Oversiktsepisode. Inndeling av vaskulittsykdommer, i henhold til Chapel Hill 2012-nomenklaturen.</p><br><p>Andre sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#42. Oversiktsepisode. Inndeling av vaskulittsykdommer, i henhold til Chapel Hill 2012-nomenklaturen.</p><br><p>Andre sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Interstitiell lungesykdom (ILD) del 3: RA-ILD, SSc-ILD og IIM-ILD</title>
			<itunes:title>Interstitiell lungesykdom (ILD) del 3: RA-ILD, SSc-ILD og IIM-ILD</itunes:title>
			<pubDate>Sun, 19 May 2024 18:40:31 GMT</pubDate>
			<itunes:duration>42:23</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/664a2131d4e903001219f357/media.mp3" length="21116508" type="audio/mpeg"/>
			<guid isPermaLink="false">664a2131d4e903001219f357</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/interstitiell-lungesykdom-ild-del-3-ra-ild-ssc-ild-og-iim-il</link>
			<acast:episodeId>664a2131d4e903001219f357</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>interstitiell-lungesykdom-ild-del-3-ra-ild-ssc-ild-og-iim-il</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5C1CY9E6hPq4YQKjv3bObWKdYiUs+nxs6j9fqniDB3ifa18VwW+aONiC0oiiCuDdcOI42X091nIzOr4qlGG9ycf]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>2</itunes:season>
			<itunes:episode>41</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#41. Oversiktsepisode. Introduksjon til ILD ved revmatoid artritt (RA-ILD), systemisk sklerose (SSc-ILD) og idiopatiske inflammatoriske myopatier (IIM-ILD, også kalt myositt-assosiert ILD (MA-ILD))</p><br><p>Andre sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#41. Oversiktsepisode. Introduksjon til ILD ved revmatoid artritt (RA-ILD), systemisk sklerose (SSc-ILD) og idiopatiske inflammatoriske myopatier (IIM-ILD, også kalt myositt-assosiert ILD (MA-ILD))</p><br><p>Andre sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Interstitiell lungesykdom (ILD) del 2: utredning</title>
			<itunes:title>Interstitiell lungesykdom (ILD) del 2: utredning</itunes:title>
			<pubDate>Sun, 07 Apr 2024 20:24:53 GMT</pubDate>
			<itunes:duration>31:41</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/6612fcbeb0ea790016c4762d/media.mp3" length="15782171" type="audio/mpeg"/>
			<guid isPermaLink="false">6612fcbeb0ea790016c4762d</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/interstitiell-lungesykdom-ild-del-2-utredning</link>
			<acast:episodeId>6612fcbeb0ea790016c4762d</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>interstitiell-lungesykdom-ild-del-2-utredning</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5AXLr4nf7+97glvSMPCoSu4zubEy7ayX5m4h5kekRoHHY7+Ys0orNWRn3pAEdccjci95lyHYiS4eVhNUltiTG6P]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>2</itunes:season>
			<itunes:episode>40</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#40. Oversiktsepisode. Interstitiell lungesykdom fra et revmatologi-perspektiv.</p><br><p>Andre sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#40. Oversiktsepisode. Interstitiell lungesykdom fra et revmatologi-perspektiv.</p><br><p>Andre sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Interstitiell lungesykdom (ILD) del 1: terminologi og etiologi</title>
			<itunes:title>Interstitiell lungesykdom (ILD) del 1: terminologi og etiologi</itunes:title>
			<pubDate>Thu, 28 Mar 2024 22:06:14 GMT</pubDate>
			<itunes:duration>49:02</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/6605d71a8268a800163ca8ec/media.mp3" length="24413613" type="audio/mpeg"/>
			<guid isPermaLink="false">6605d71a8268a800163ca8ec</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/interstitiell-lungesykdom-ild-del-1-terminologi-og-etiologi</link>
			<acast:episodeId>6605d71a8268a800163ca8ec</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>interstitiell-lungesykdom-ild-del-1-terminologi-og-etiologi</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5DXD2djK/UNyQCBze+Nb8uHNNr1bPXu+zikvs44V1KJYHC7PuioE09dtTRO4um4r/xxqM4mefETBMaten+tEd1h]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>2</itunes:season>
			<itunes:episode>39</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#39. Oversiktsepisode. Interstitiell lungesykdom fra et revmatologi-perspektiv.</p><br><p>Temaer som dekkes: IIP, CTD-ILD, IPF, UIP, NSIP, OP, COP, AIP, LIP, PF-ILD og PPF</p><br><p>Andre sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#39. Oversiktsepisode. Interstitiell lungesykdom fra et revmatologi-perspektiv.</p><br><p>Temaer som dekkes: IIP, CTD-ILD, IPF, UIP, NSIP, OP, COP, AIP, LIP, PF-ILD og PPF</p><br><p>Andre sesong er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Spondyloartritt (SpA) del 8: axSpA - kasuistikker med Gunnstein Bakland</title>
			<itunes:title>Spondyloartritt (SpA) del 8: axSpA - kasuistikker med Gunnstein Bakland</itunes:title>
			<pubDate>Mon, 05 Feb 2024 06:16:09 GMT</pubDate>
			<itunes:duration>59:18</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/65b2e8eda4e7cb001688a534/media.mp3" length="29608689" type="audio/mpeg"/>
			<guid isPermaLink="false">65b2e8eda4e7cb001688a534</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/spondyloartritt-spa-del-8-axspa-kasuistikker-med-gunnstein-b</link>
			<acast:episodeId>65b2e8eda4e7cb001688a534</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>spondyloartritt-spa-del-8-axspa-kasuistikker-med-gunnstein-b</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5BCnMlXI3XaKO5dMR3j+skxjiGJUL3/6SEAgmYMWZIhQMlVkDTu3Z2qllQKWNJv8LAdp1ioCxrcev4h7ccSBTjN]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>2</itunes:season>
			<itunes:episode>38</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#38. Ekspertepisode. Gjest: Gunnstein Bakland. Overlege ved Revmatologisk avdeling, UNN. Førsteamanuensis ved UiT.</p><br><p>I denne episoden: axSpA-kasuistikker</p><br><p>Andre sesong er finansiert gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#38. Ekspertepisode. Gjest: Gunnstein Bakland. Overlege ved Revmatologisk avdeling, UNN. Førsteamanuensis ved UiT.</p><br><p>I denne episoden: axSpA-kasuistikker</p><br><p>Andre sesong er finansiert gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Spondyloartritt (SpA) del 7: axSpA - tips og triks med Gunnstein Bakland</title>
			<itunes:title>Spondyloartritt (SpA) del 7: axSpA - tips og triks med Gunnstein Bakland</itunes:title>
			<pubDate>Thu, 25 Jan 2024 21:15:15 GMT</pubDate>
			<itunes:duration>51:09</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/65b1fc3dc30ca900163883fb/media.mp3" length="25542168" type="audio/mpeg"/>
			<guid isPermaLink="false">65b1fc3dc30ca900163883fb</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/spondyloartritt-spa-del-7a-axspa-ekspertepisode-med-gunnstei</link>
			<acast:episodeId>65b1fc3dc30ca900163883fb</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>spondyloartritt-spa-del-7a-axspa-ekspertepisode-med-gunnstei</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5D3CvV2E2lL5O7j7uFTR4AFiO6dJQWI/+BFvdywNRDp2mbyBE3IZF4I88Jp4D9MwNYN3ghH+SYNRlMbJH8PV13v]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>2</itunes:season>
			<itunes:episode>37</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#37. Ekspertepisode. Gjest: Gunnstein Bakland. Overlege ved Revmatologisk avdeling, UNN. Førsteamanuensis ved UiT.</p><br><p>I denne episoden: generelle tips og triks om axSpA</p><br><p>Andre sesong er finansiert gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#37. Ekspertepisode. Gjest: Gunnstein Bakland. Overlege ved Revmatologisk avdeling, UNN. Førsteamanuensis ved UiT.</p><br><p>I denne episoden: generelle tips og triks om axSpA</p><br><p>Andre sesong er finansiert gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Norsk revmatologisk forenings julemøte 2023</title>
			<itunes:title>Norsk revmatologisk forenings julemøte 2023</itunes:title>
			<pubDate>Fri, 01 Dec 2023 04:15:48 GMT</pubDate>
			<itunes:duration>24:58</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/6567b80f6b969e0012b38280/media.mp3" length="35791216" type="audio/mpeg"/>
			<guid isPermaLink="false">6567b80f6b969e0012b38280</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/norsk-revmatologisk-forenings-julemte-2023</link>
			<acast:episodeId>6567b80f6b969e0012b38280</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>norsk-revmatologisk-forenings-julemte-2023</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5CHsXlJWczZxZT/rLhW/VmmRcQ/EjI84LAdRcTpFcCixm+TpQmbhFvW5sNa8UNqlrEq+iRFEAnptLHi2MZ4ccRt]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>2</itunes:season>
			<itunes:episode>36</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#36. Bonusepisode. Reisebrev fra NRFs julemøte, med "take home messages" fra forelesere</p><br><p>Andre sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#36. Bonusepisode. Reisebrev fra NRFs julemøte, med "take home messages" fra forelesere</p><br><p>Andre sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>CAR-T i revmatologi del 4: kasuistikker</title>
			<itunes:title>CAR-T i revmatologi del 4: kasuistikker</itunes:title>
			<pubDate>Sun, 12 Nov 2023 21:59:07 GMT</pubDate>
			<itunes:duration>17:26</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/65513c218290a1001250ae94/media.mp3" length="24985653" type="audio/mpeg"/>
			<guid isPermaLink="false">65513c218290a1001250ae94</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/car-t-i-revmatologi-del-4-kasuistikker</link>
			<acast:episodeId>65513c218290a1001250ae94</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>car-t-i-revmatologi-del-4-kasuistikker</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5AiSQaWpz+YGpAr6hIwZUgvMf1L/wh/pAwnwVPgs+SVk1RIqm38/RH7u5w0c7aI9MTH4VSBqSboH9oXMzfyFRVL]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>2</itunes:season>
			<itunes:episode>35</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#35. Oversiktsepisode. Gjest: Ole Jakob Sletten, LIS i kardiologi ved Stavanger universitetssjukehus og stipendiat ved Rikshospitalet.</p><br><p>Lenke til omtalte artikler fra Georg Schett i gruppe:</p><p><a href="https://pubmed.ncbi.nlm.nih.gov/37748491/" rel="noopener noreferrer" target="_blank">Review (Lancet 2023)</a></p><p><a href="https://ard.bmj.com/content/82/8/1117" rel="noopener noreferrer" target="_blank">Systemisk sklerose (ARD 2023)</a></p><p><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00023-5/fulltext" rel="noopener noreferrer" target="_blank">Antisyntetasesyndrom (Lancet 2023)</a></p><p><a href="https://www.nature.com/articles/s41591-022-02017-5" rel="noopener noreferrer" target="_blank">SLE case series (Nature 2022)</a></p><p><a href="Første SLE-case (NEJM 2021)" rel="noopener noreferrer" target="_blank">Første SLE-case (NEJM 2021)</a></p><br><p>Andre sesong er finansiert gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#35. Oversiktsepisode. Gjest: Ole Jakob Sletten, LIS i kardiologi ved Stavanger universitetssjukehus og stipendiat ved Rikshospitalet.</p><br><p>Lenke til omtalte artikler fra Georg Schett i gruppe:</p><p><a href="https://pubmed.ncbi.nlm.nih.gov/37748491/" rel="noopener noreferrer" target="_blank">Review (Lancet 2023)</a></p><p><a href="https://ard.bmj.com/content/82/8/1117" rel="noopener noreferrer" target="_blank">Systemisk sklerose (ARD 2023)</a></p><p><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00023-5/fulltext" rel="noopener noreferrer" target="_blank">Antisyntetasesyndrom (Lancet 2023)</a></p><p><a href="https://www.nature.com/articles/s41591-022-02017-5" rel="noopener noreferrer" target="_blank">SLE case series (Nature 2022)</a></p><p><a href="Første SLE-case (NEJM 2021)" rel="noopener noreferrer" target="_blank">Første SLE-case (NEJM 2021)</a></p><br><p>Andre sesong er finansiert gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>CAR-T i revmatologi del 3: utfordringer</title>
			<itunes:title>CAR-T i revmatologi del 3: utfordringer</itunes:title>
			<pubDate>Sun, 12 Nov 2023 21:58:56 GMT</pubDate>
			<itunes:duration>26:38</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/6551310bfd344d00138ca395/media.mp3" length="38169641" type="audio/mpeg"/>
			<guid isPermaLink="false">6551310bfd344d00138ca395</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/car-t-i-revmatologi-del-3-utfordringer</link>
			<acast:episodeId>6551310bfd344d00138ca395</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>car-t-i-revmatologi-del-3-utfordringer</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5CykhmW07VSZ4CJ/Ztw3u/MlP5vBl3K/8XAKWXC1uZstv/7HyWr8raCafnUHmZj6aUvULQ154ajA60FN0FVaIJj]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>2</itunes:season>
			<itunes:episode>34</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#34. Oversiktsepisode. Gjest: Ole Jakob Sletten, LIS i kardiologi ved Stavanger universitetssjukehus og stipendiat ved Rikshospitalet.</p><br><p><a href="https://pubmed.ncbi.nlm.nih.gov/37748491/" rel="noopener noreferrer" target="_blank">Lenke til review av Georg Schett et al.</a></p><br><p>Andre sesong er finansiert gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#34. Oversiktsepisode. Gjest: Ole Jakob Sletten, LIS i kardiologi ved Stavanger universitetssjukehus og stipendiat ved Rikshospitalet.</p><br><p><a href="https://pubmed.ncbi.nlm.nih.gov/37748491/" rel="noopener noreferrer" target="_blank">Lenke til review av Georg Schett et al.</a></p><br><p>Andre sesong er finansiert gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>CAR-T i revmatologi del 2: metoden fra høsting til infusjon</title>
			<itunes:title>CAR-T i revmatologi del 2: metoden fra høsting til infusjon</itunes:title>
			<pubDate>Sun, 12 Nov 2023 21:55:59 GMT</pubDate>
			<itunes:duration>9:38</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/6550d03b03445c0011e3843a/media.mp3" length="13824165" type="audio/mpeg"/>
			<guid isPermaLink="false">6550d03b03445c0011e3843a</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/car-t-i-revmatologi-del-2-prosedyren</link>
			<acast:episodeId>6550d03b03445c0011e3843a</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>car-t-i-revmatologi-del-2-prosedyren</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5CPjctqTrS6NU2BKXDNO/MykkaGqVhWurKwcxs++Q/2gVXw0MKENAicIb0lPrlgvbLBkAd/W/xxuDrJK8Zeuqjc]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>2</itunes:season>
			<itunes:episode>33</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#33. Oversiktsepisode. Gjest: Ole Jakob Sletten, LIS i kardiologi ved Stavanger universitetssjukehus og stipendiat ved Rikshospitalet.</p><br><p><a href="https://pubmed.ncbi.nlm.nih.gov/37748491/" rel="noopener noreferrer" target="_blank">Lenke til review av Georg Schett et al.</a></p><br><p>Andre sesong er finansiert gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#33. Oversiktsepisode. Gjest: Ole Jakob Sletten, LIS i kardiologi ved Stavanger universitetssjukehus og stipendiat ved Rikshospitalet.</p><br><p><a href="https://pubmed.ncbi.nlm.nih.gov/37748491/" rel="noopener noreferrer" target="_blank">Lenke til review av Georg Schett et al.</a></p><br><p>Andre sesong er finansiert gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>CAR-T i revmatologi del 1: immunologi og prinsipp</title>
			<itunes:title>CAR-T i revmatologi del 1: immunologi og prinsipp</itunes:title>
			<pubDate>Sun, 12 Nov 2023 21:53:03 GMT</pubDate>
			<itunes:duration>55:32</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/6550cb4446e5c900115269bc/media.mp3" length="79574527" type="audio/mpeg"/>
			<guid isPermaLink="false">6550cb4446e5c900115269bc</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/car-t-i-revma-del-1-immunologi-og-prinsipp</link>
			<acast:episodeId>6550cb4446e5c900115269bc</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>car-t-i-revma-del-1-immunologi-og-prinsipp</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5AEGa7L+sY89M5XLXKaw6FU1cb0bkjRW+k56za6JRbwCzlPTKZAb003LsJlvVbOI7G9yT0XuoquhprXMb5lw4u/]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>2</itunes:season>
			<itunes:episode>32</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#32. Oversiktsepisode. Gjest: Ole Jakob Sletten, LIS i kardiologi ved Stavanger universitetssjukehus og stipendiat ved Rikshospitalet.</p><br><p>Temaer som dekkes: basal B- og T-celleimmunologi, og ulike former for B-celledeplesjon (rituksimab, HMAS, CD19 CAR-T)</p><br><p><a href="https://pubmed.ncbi.nlm.nih.gov/37748491/" rel="noopener noreferrer" target="_blank">Lenke til review av Georg Schett et al.</a></p><br><p>Andre sesong er finansiert gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#32. Oversiktsepisode. Gjest: Ole Jakob Sletten, LIS i kardiologi ved Stavanger universitetssjukehus og stipendiat ved Rikshospitalet.</p><br><p>Temaer som dekkes: basal B- og T-celleimmunologi, og ulike former for B-celledeplesjon (rituksimab, HMAS, CD19 CAR-T)</p><br><p><a href="https://pubmed.ncbi.nlm.nih.gov/37748491/" rel="noopener noreferrer" target="_blank">Lenke til review av Georg Schett et al.</a></p><br><p>Andre sesong er finansiert gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Whipples sykdom del 3: klinikk og diagnostikk</title>
			<itunes:title>Whipples sykdom del 3: klinikk og diagnostikk</itunes:title>
			<pubDate>Wed, 01 Nov 2023 18:59:31 GMT</pubDate>
			<itunes:duration>40:56</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/6541798ed96b460012767052/media.mp3" length="58672187" type="audio/mpeg"/>
			<guid isPermaLink="false">6541798ed96b460012767052</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/whipples-sykdom-del-3-klinikk-og-diagnostikk</link>
			<acast:episodeId>6541798ed96b460012767052</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>whipples-sykdom-del-3-klinikk-og-diagnostikk</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5Cit8hANr+T8tKMbYeOhI/c1FAKjR4B1bsZ1Q4GgvtH6n1DrIOe2HV7wGsevRp21CXsBOBAl8xyXiJJcICMmBJx]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>2</itunes:season>
			<itunes:episode>31</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#31. Oversiktsepisode. Gjest: Thomas Woldeyesus, LIS i ortopedi ved Stavanger universitetssjukehus.</p><br><p><a href="https://www.youtube.com/watch?v=Zwb5bt749Jo" rel="noopener noreferrer" target="_blank">YouTube-film: okulomastikatorisk myorytmi</a></p><br><p><a href="https://tidsskriftet.no/2017/10/noe-laere-av/en-kvinne-i-60-arene-med-diare-og-leddsmerter" rel="noopener noreferrer" target="_blank">Kasuistikk i Tidsskrift for Den norske legeforening</a></p><br><p>Sesong 2 er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#31. Oversiktsepisode. Gjest: Thomas Woldeyesus, LIS i ortopedi ved Stavanger universitetssjukehus.</p><br><p><a href="https://www.youtube.com/watch?v=Zwb5bt749Jo" rel="noopener noreferrer" target="_blank">YouTube-film: okulomastikatorisk myorytmi</a></p><br><p><a href="https://tidsskriftet.no/2017/10/noe-laere-av/en-kvinne-i-60-arene-med-diare-og-leddsmerter" rel="noopener noreferrer" target="_blank">Kasuistikk i Tidsskrift for Den norske legeforening</a></p><br><p>Sesong 2 er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Whipples sykdom del 2: patofysiologi</title>
			<itunes:title>Whipples sykdom del 2: patofysiologi</itunes:title>
			<pubDate>Mon, 16 Oct 2023 17:51:50 GMT</pubDate>
			<itunes:duration>28:09</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/65231246ed688f0011e9b179/media.mp3" length="40353424" type="audio/mpeg"/>
			<guid isPermaLink="false">65231246ed688f0011e9b179</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/whipples-sykdom-del-2-patofysiologi</link>
			<acast:episodeId>65231246ed688f0011e9b179</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>whipples-sykdom-del-2-patofysiologi</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6ZsoxhINu4Ad7VkAnsB5MGv7X/espNyex+FzX1yARaqUErOnUYCc5KxuqLdPk5VNA5shRbSTiVdP5n8p0wAkVJBmUhf15j/2CqYH4u85YV2wWM=]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>2</itunes:season>
			<itunes:episode>30</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#30. Oversiktsepisode. Gjest: Thomas Woldeyesus, LIS i ortopedi ved Stavanger universitetssjukehus.</p><br><p>Sesong 2 er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#30. Oversiktsepisode. Gjest: Thomas Woldeyesus, LIS i ortopedi ved Stavanger universitetssjukehus.</p><br><p>Sesong 2 er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Whipples sykdom del 1: kasuistikk</title>
			<itunes:title>Whipples sykdom del 1: kasuistikk</itunes:title>
			<pubDate>Wed, 11 Oct 2023 04:01:41 GMT</pubDate>
			<itunes:duration>27:45</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/652311ee74b8300011776f2a/media.mp3" length="39782500" type="audio/mpeg"/>
			<guid isPermaLink="false">652311ee74b8300011776f2a</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/whipples-sykdom-del-1-kasuistikk</link>
			<acast:episodeId>652311ee74b8300011776f2a</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>whipples-sykdom-del-1-kasuistikk</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5CQJue3TnfFMFCDG5mRLZh3z983ah//YhUHZSsNd4+t6CFv4ccBCNxgCQQDdogl8bxYWzchZUGHVQBQ+sVemGrB]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>2</itunes:season>
			<itunes:episode>29</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#29. Oversiktsepisode. Gjest: Thomas Woldeyesus, LIS i ortopedi ved Stavanger universitetssjukehus.</p><br><p>Omtalt kasuistikk: <a href="https://tidsskriftet.no/2017/10/noe-laere-av/en-kvinne-i-60-arene-med-diare-og-leddsmerter" rel="noopener noreferrer" target="_blank">Vikse J et al. En kvinne i 60-årene med diaré og leddsmerter. Tidsskrift for Den norske legeforening.</a></p><br><p>Sesong 2 er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#29. Oversiktsepisode. Gjest: Thomas Woldeyesus, LIS i ortopedi ved Stavanger universitetssjukehus.</p><br><p>Omtalt kasuistikk: <a href="https://tidsskriftet.no/2017/10/noe-laere-av/en-kvinne-i-60-arene-med-diare-og-leddsmerter" rel="noopener noreferrer" target="_blank">Vikse J et al. En kvinne i 60-årene med diaré og leddsmerter. Tidsskrift for Den norske legeforening.</a></p><br><p>Sesong 2 er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Introduksjon: sesong 2</title>
			<itunes:title>Introduksjon: sesong 2</itunes:title>
			<pubDate>Wed, 11 Oct 2023 04:00:31 GMT</pubDate>
			<itunes:duration>0:40</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/65231139ed688f0011e91018/media.mp3" length="978080" type="audio/mpeg"/>
			<guid isPermaLink="false">65231139ed688f0011e91018</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/introduksjon-sesong-2</link>
			<acast:episodeId>65231139ed688f0011e91018</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>introduksjon-sesong-2</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6ZsoxhINu4Ad7VkAnsB5MGv7cZZmfKPQRHG8335nlTtkiN9APBzPb6m3JdGn+Wza7X6HS9Ddk5/35Hpa3VVpGwLaq+JHQcevr10RHX2wZcTyAo=]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>2</itunes:season>
			<itunes:episode>28</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#28. Introduksjon til sesong 2.</p><br><p>Sesong 2 er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#28. Introduksjon til sesong 2.</p><br><p>Sesong 2 er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Spondyloartritt (SpA) del 6: differensialdiagnostisk quiz</title>
			<itunes:title>Spondyloartritt (SpA) del 6: differensialdiagnostisk quiz</itunes:title>
			<pubDate>Mon, 25 Sep 2023 03:00:01 GMT</pubDate>
			<itunes:duration>13:05</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/64e12fea8aface001165b175/media.mp3" length="18757555" type="audio/mpeg"/>
			<guid isPermaLink="false">64e12fea8aface001165b175</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/spondyloartritt-spa-del-6-differensialdiagnostisk-quiz</link>
			<acast:episodeId>64e12fea8aface001165b175</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>spondyloartritt-spa-del-6-differensialdiagnostisk-quiz</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5Dulo+E5kS+AGRnkGaVwtmwCPeKWjOtEbM+g/qTR55lwdvSt04OiRagybW4G34zcpPuKQIm6+zMoJSB8fnrVCHq]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>27</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#27. Oversiktsepisode. Gjest: Maria Skeie Meltveit, sykehjemslege i Stavanger og (snart) spesialist i allmennmedisin.</p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#27. Oversiktsepisode. Gjest: Maria Skeie Meltveit, sykehjemslege i Stavanger og (snart) spesialist i allmennmedisin.</p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Spondyloartritt (SpA) del 5: reaktiv artritt</title>
			<itunes:title>Spondyloartritt (SpA) del 5: reaktiv artritt</itunes:title>
			<pubDate>Mon, 18 Sep 2023 03:00:22 GMT</pubDate>
			<itunes:duration>16:03</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/64e12d6ba136c900111a20f2/media.mp3" length="23017729" type="audio/mpeg"/>
			<guid isPermaLink="false">64e12d6ba136c900111a20f2</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/spondyloartritt-spa-del-5-reaktiv-artritt</link>
			<acast:episodeId>64e12d6ba136c900111a20f2</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>spondyloartritt-spa-del-5-reaktiv-artritt</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5DvvJC96uga+M2AhamuRWCn326luDAV30a2d4KlpwkrWF3feZJgvzQNgjd0t3qf5/+y9guZDmxfWWEHBJAQN9Zx]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>26</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#26. Oversiktsepisode. Gjest: Maria Skeie Meltveit, sykehjemslege i Stavanger og (snart) spesialist i allmennmedisin.</p><br><p>Mikrober omtalt i denne episoden: campylobacter, salmonella, shigella, yersinia, klamydia, intravesikale BCG-instillasjoner. Noen kilder oppgir i tillegg andre mikrober.</p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#26. Oversiktsepisode. Gjest: Maria Skeie Meltveit, sykehjemslege i Stavanger og (snart) spesialist i allmennmedisin.</p><br><p>Mikrober omtalt i denne episoden: campylobacter, salmonella, shigella, yersinia, klamydia, intravesikale BCG-instillasjoner. Noen kilder oppgir i tillegg andre mikrober.</p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Spondyloartritt (SpA) del 4: psoriasisartritt (PsA)</title>
			<itunes:title>Spondyloartritt (SpA) del 4: psoriasisartritt (PsA)</itunes:title>
			<pubDate>Mon, 11 Sep 2023 03:00:54 GMT</pubDate>
			<itunes:duration>11:26</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/64e126884189310011d584dc/media.mp3" length="16383712" type="audio/mpeg"/>
			<guid isPermaLink="false">64e126884189310011d584dc</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/spondyloartritt-spa-del-4-psoriasisartritt-psa</link>
			<acast:episodeId>64e126884189310011d584dc</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>spondyloartritt-spa-del-4-psoriasisartritt-psa</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5A/aD6zL7VeRAqr8E8821raQUZPzcv7QXUFjZ7hQFmMUMgCeZMtcUY0CGAuYnsQ3aPvAIPHmvrXFQUj+Plky6sy]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>25</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#25. Oversiktsepisode. Gjest: Maria Skeie Meltveit, sykehjemslege i Stavanger og (snart) spesialist i allmennmedisin.</p><br><p>Lenke til omtalt artikkel: <a href="https://pubmed.ncbi.nlm.nih.gov/16206347/" rel="noopener noreferrer" target="_blank">Madland TM et al. Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. J. Rheum. 2005.</a></p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#25. Oversiktsepisode. Gjest: Maria Skeie Meltveit, sykehjemslege i Stavanger og (snart) spesialist i allmennmedisin.</p><br><p>Lenke til omtalt artikkel: <a href="https://pubmed.ncbi.nlm.nih.gov/16206347/" rel="noopener noreferrer" target="_blank">Madland TM et al. Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. J. Rheum. 2005.</a></p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Spondyloartritt (SpA) del 3: aksial SpA (axSpA)</title>
			<itunes:title>Spondyloartritt (SpA) del 3: aksial SpA (axSpA)</itunes:title>
			<pubDate>Mon, 04 Sep 2023 03:00:02 GMT</pubDate>
			<itunes:duration>14:43</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/64e125bc9aa6330012b0ed39/media.mp3" length="21107751" type="audio/mpeg"/>
			<guid isPermaLink="false">64e125bc9aa6330012b0ed39</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/spondyloartritt-spa-del-3-aksial-spa-axspa</link>
			<acast:episodeId>64e125bc9aa6330012b0ed39</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>spondyloartritt-spa-del-3-aksial-spa-axspa</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5BbzqSx9FLu/X3nSJM9/uIYipUl1xzLQgMpCnslIZ79Rwcp3DImeDmuPwfNB1JNT9QcKbtF468eoPL/BDrWDKiw]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>24</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#24. Oversiktsepisode. Gjest: Maria Skeie Meltveit, sykehjemslege i Stavanger og (snart) spesialist i allmennmedisin.</p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#24. Oversiktsepisode. Gjest: Maria Skeie Meltveit, sykehjemslege i Stavanger og (snart) spesialist i allmennmedisin.</p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Spondyloartritt (SpA) del 2: manifestasjoner</title>
			<itunes:title>Spondyloartritt (SpA) del 2: manifestasjoner</itunes:title>
			<pubDate>Mon, 28 Aug 2023 03:00:21 GMT</pubDate>
			<itunes:duration>34:06</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/64e124c22cfe010011786ad4/media.mp3" length="48860297" type="audio/mpeg"/>
			<guid isPermaLink="false">64e124c22cfe010011786ad4</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/spondyloartritt-spa-del-2-manifestasjoner</link>
			<acast:episodeId>64e124c22cfe010011786ad4</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>spondyloartritt-spa-del-2-manifestasjoner</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5BOPbkYWrdAOabv1nFSQhyFAvmCzc3DJzZytxB9ed4U9+H6VnI1J9mTaFn3Tz8dxzWInu/hTGyqtqu9VAnKVrJp]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>23</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#23. Oversiktsepisode. Gjest: Maria Skeie Meltveit, sykehjemslege i Stavanger og (snart) spesialist i allmennmedisin.</p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#23. Oversiktsepisode. Gjest: Maria Skeie Meltveit, sykehjemslege i Stavanger og (snart) spesialist i allmennmedisin.</p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Spondyloartritt (SpA) del 1: konsept og terminologi</title>
			<itunes:title>Spondyloartritt (SpA) del 1: konsept og terminologi</itunes:title>
			<pubDate>Mon, 21 Aug 2023 03:00:09 GMT</pubDate>
			<itunes:duration>33:46</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/64e12357ce03de00118c8a87/media.mp3" length="48399464" type="audio/mpeg"/>
			<guid isPermaLink="false">64e12357ce03de00118c8a87</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/spondyloartritt-spa-del-1-konsept-og-terminologi</link>
			<acast:episodeId>64e12357ce03de00118c8a87</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>spondyloartritt-spa-del-1-konsept-og-terminologi</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5Adp4+SV2k2/fbzqee+kAWYhDyL/oTlaZdxz0SxP/hcDiWP1aEtNvncmrNrlwEwOYN30yrb2ghPCer3UeOxVIqI]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>22</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#22. Oversiktsepisode. Gjest: Maria Skeie Meltveit, sykehjemslege i Stavanger og (snart) spesialist i allmennmedisin.</p><br><p><a href="https://pubmed.ncbi.nlm.nih.gov/15708947/" rel="noopener noreferrer" target="_blank">Lenke til artikkel om "lumpers and splitters" fra 2005 (artikkelen omtales helt til slutt i episoden)</a>.</p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#22. Oversiktsepisode. Gjest: Maria Skeie Meltveit, sykehjemslege i Stavanger og (snart) spesialist i allmennmedisin.</p><br><p><a href="https://pubmed.ncbi.nlm.nih.gov/15708947/" rel="noopener noreferrer" target="_blank">Lenke til artikkel om "lumpers and splitters" fra 2005 (artikkelen omtales helt til slutt i episoden)</a>.</p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Immunmodulering versus immunsuppresjon: terminologi</title>
			<itunes:title>Immunmodulering versus immunsuppresjon: terminologi</itunes:title>
			<pubDate>Tue, 25 Jul 2023 21:08:54 GMT</pubDate>
			<itunes:duration>6:43</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/64c01f1585617f0011524fb8/media.mp3" length="9633787" type="audio/mpeg"/>
			<guid isPermaLink="false">64c01f1585617f0011524fb8</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/immunmodulering-versus-immunsuppresjon</link>
			<acast:episodeId>64c01f1585617f0011524fb8</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>immunmodulering-versus-immunsuppresjon</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5BeRV8ouWBVBuZFAQmrISjqqc8+pk4Gis+nYu4u5WzeLs4fa4fk7u/6YnS5Mu6aS+FVeSqZByZszh2N0gcS+y4f]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>21</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1727724529195-9cd59f2e-d374-4fc8-b634-fb6f41fad08d.jpeg"/>
			<description><![CDATA[<p>#21. Bonusepisode. Bør vi kalle medikamentene i revmatologien "immunmodulerende" eller "immunsupprimerende"?</p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>#21. Bonusepisode. Bør vi kalle medikamentene i revmatologien "immunmodulerende" eller "immunsupprimerende"?</p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Høydepunkter fra EULAR 2023</title>
			<itunes:title>Høydepunkter fra EULAR 2023</itunes:title>
			<pubDate>Wed, 07 Jun 2023 04:30:32 GMT</pubDate>
			<itunes:duration>35:18</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/647f952ab19ea100118e1541/media.mp3" length="50593202" type="audio/mpeg"/>
			<guid isPermaLink="false">647f952ab19ea100118e1541</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/hydepunkter-fra-eular-2023</link>
			<acast:episodeId>647f952ab19ea100118e1541</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>hydepunkter-fra-eular-2023</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5CigaaRaTzEQ2jTpjwBBrzOqmE+i/v5gUwSBFzVbZ5ZGOzroXE2mvj0N961HAJDTFA7iBOFFiXboG59+ii7aT8J]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>20</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1666189581862-5d71f840859a886c4750316fe150711f.jpeg"/>
			<description><![CDATA[<p>Kolleger deler noen av sine høydepunkt fra EULAR 2023 i Milano. </p><br><p>(Første sesong av podcasten er finansiert av Norsk revmatologisk forening)</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Kolleger deler noen av sine høydepunkt fra EULAR 2023 i Milano. </p><br><p>(Første sesong av podcasten er finansiert av Norsk revmatologisk forening)</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Glomerulonefritt del 3 (lupusnefritt): ekspertepisode med Gudrun Norby</title>
			<itunes:title>Glomerulonefritt del 3 (lupusnefritt): ekspertepisode med Gudrun Norby</itunes:title>
			<pubDate>Wed, 10 May 2023 04:30:32 GMT</pubDate>
			<itunes:duration>47:45</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/645aa9cc1d595f0011928b4c/media.mp3" length="68429686" type="audio/mpeg"/>
			<guid isPermaLink="false">645aa9cc1d595f0011928b4c</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/glomerulonefritt-del-3-lupusnefritt-ekspertepisode-med-gudru</link>
			<acast:episodeId>645aa9cc1d595f0011928b4c</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>glomerulonefritt-del-3-lupusnefritt-ekspertepisode-med-gudru</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5BeVAJq5BDlzazSrHTTAwfEV4X9hoQRLloePKstCEL/YQU+xOLgdctDmOrtwMRfq5ly9S8k2w8MBvTHxT0KtsLg]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>19</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1666189581862-5d71f840859a886c4750316fe150711f.jpeg"/>
			<description><![CDATA[<p>Ekspertepisode. Gjest: Gudrun Norby, overlege ved Revmatologisk avdeling, Rikshospitalet.</p><br><p>(Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening)</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Ekspertepisode. Gjest: Gudrun Norby, overlege ved Revmatologisk avdeling, Rikshospitalet.</p><br><p>(Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening)</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>IgG4-relatert sykdom del 4: ekspertepisode med Øyvind Midtvedt</title>
			<itunes:title>IgG4-relatert sykdom del 4: ekspertepisode med Øyvind Midtvedt</itunes:title>
			<pubDate>Sun, 02 Apr 2023 17:50:24 GMT</pubDate>
			<itunes:duration>36:53</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/642481884fcc90001182c2e0/media.mp3" length="52856509" type="audio/mpeg"/>
			<guid isPermaLink="false">642481884fcc90001182c2e0</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/igg4-relatert-sykdom-del-4-ekspertepisode-med-yvind-midtvedt</link>
			<acast:episodeId>642481884fcc90001182c2e0</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>igg4-relatert-sykdom-del-4-ekspertepisode-med-yvind-midtvedt</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5CFKId6la0EAMZExPlGOi/s9lNpTtVs7kVsBPhcVRfItLxeJYPEBIMMnVtGXuXcFyoj5ulgWH7lU10dmdTuCuHk]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>18</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1666189581862-5d71f840859a886c4750316fe150711f.jpeg"/>
			<description><![CDATA[<p>Ekspertepisode. Gjest: Øyvind Midtvedt, overlege ved Revmatologisk avdeling, Rikshospitalet.</p><br><p>(Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening)</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Ekspertepisode. Gjest: Øyvind Midtvedt, overlege ved Revmatologisk avdeling, Rikshospitalet.</p><br><p>(Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening)</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Hvorfor er CRP normal ved aktiv SLE?</title>
			<itunes:title>Hvorfor er CRP normal ved aktiv SLE?</itunes:title>
			<pubDate>Fri, 10 Mar 2023 11:31:57 GMT</pubDate>
			<itunes:duration>8:55</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/640a11d709d94b0011c8b8fc/media.mp3" length="12793119" type="audio/mpeg"/>
			<guid isPermaLink="false">640a11d709d94b0011c8b8fc</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/crp-ved-sle</link>
			<acast:episodeId>640a11d709d94b0011c8b8fc</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>crp-ved-sle</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5DWBcuMPqSXcPX601jo/YDQjV1EV7RyvK9w8GlY/lDJP2g2yPgUvkqtKHQ6WnULUDLMKxMItdG0uwiPW/VCwKwj]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>17</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1666189581862-5d71f840859a886c4750316fe150711f.jpeg"/>
			<description><![CDATA[<p>Bonusepisode om type I interferoner, interleukin 6 og CRP ved SLE og andre bindevevssykdommer.</p><br><p>Omtalte artikler: <a href="https://pubmed.ncbi.nlm.nih.gov/33584722/" rel="noopener noreferrer" target="_blank">Enocsson et al. Front Immunol. 2021</a>. <a href="https://pubmed.ncbi.nlm.nih.gov/34945133/" rel="noopener noreferrer" target="_blank">Enocsson et al. J. Clin Med. 2021</a>.</p><br><p>Første sesong av podcasten er finansiert gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Bonusepisode om type I interferoner, interleukin 6 og CRP ved SLE og andre bindevevssykdommer.</p><br><p>Omtalte artikler: <a href="https://pubmed.ncbi.nlm.nih.gov/33584722/" rel="noopener noreferrer" target="_blank">Enocsson et al. Front Immunol. 2021</a>. <a href="https://pubmed.ncbi.nlm.nih.gov/34945133/" rel="noopener noreferrer" target="_blank">Enocsson et al. J. Clin Med. 2021</a>.</p><br><p>Første sesong av podcasten er finansiert gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Glomerulonefritt del 2: SLE og småkarsvaskulitter</title>
			<itunes:title>Glomerulonefritt del 2: SLE og småkarsvaskulitter</itunes:title>
			<pubDate>Wed, 01 Mar 2023 07:00:24 GMT</pubDate>
			<itunes:duration>39:50</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/63f726b50a0d23001160aadb/media.mp3" length="57094337" type="audio/mpeg"/>
			<guid isPermaLink="false">63f726b50a0d23001160aadb</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/16-glomerulonefritt-del-2-nyreaffeksjon-ved-sle-og-smakarsva</link>
			<acast:episodeId>63f726b50a0d23001160aadb</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>16-glomerulonefritt-del-2-nyreaffeksjon-ved-sle-og-smakarsva</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5C807eFLIEPQJkiVm1y6jpRjRmd7rgGGN2lyackI6eIfv6dWIH7yJjDORemSh4AW1S0s5u9Ve+Z/BwSsfEzXY+t]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>16</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1677141677836-dc2fb9154800473465ecc427ca518ccd.jpeg"/>
			<description><![CDATA[<p><strong>NB!</strong> Hvis illustrasjonen av glomeruli ikke vises (f.eks. i Apple podcast): <a href="https://shows.acast.com/revmatologi/episodes/16-glomerulonefritt-del-2-nyreaffeksjon-ved-sle-og-smakarsva" rel="noopener noreferrer" target="_blank">trykk her for å se den</a>.</p><br><p>Oversiktsepisode om glomerulonefritt fra et revmatologiperspektiv. Gjest: Egil Riveland, konstituert overlege ved Kardiologisk avdeling, Stavanger universitetssjukehus.</p><br><p>Glomerulære presentasjoner av anti-GBM sykdom, lupusnefritt, IgA-vaskulitt og ANCA-assosiert vaskulitt</p><br><p>Første sesong av podcasten er finansiert gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p><strong>NB!</strong> Hvis illustrasjonen av glomeruli ikke vises (f.eks. i Apple podcast): <a href="https://shows.acast.com/revmatologi/episodes/16-glomerulonefritt-del-2-nyreaffeksjon-ved-sle-og-smakarsva" rel="noopener noreferrer" target="_blank">trykk her for å se den</a>.</p><br><p>Oversiktsepisode om glomerulonefritt fra et revmatologiperspektiv. Gjest: Egil Riveland, konstituert overlege ved Kardiologisk avdeling, Stavanger universitetssjukehus.</p><br><p>Glomerulære presentasjoner av anti-GBM sykdom, lupusnefritt, IgA-vaskulitt og ANCA-assosiert vaskulitt</p><br><p>Første sesong av podcasten er finansiert gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Glomerulonefritt del 1: patofysiologi, presentasjoner og utredning</title>
			<itunes:title>Glomerulonefritt del 1: patofysiologi, presentasjoner og utredning</itunes:title>
			<pubDate>Fri, 24 Feb 2023 11:59:07 GMT</pubDate>
			<itunes:duration>52:24</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/63f359f15d4e130011c01417/media.mp3" length="75088999" type="audio/mpeg"/>
			<guid isPermaLink="false">63f359f15d4e130011c01417</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/15-glomerulonefritt-del-1</link>
			<acast:episodeId>63f359f15d4e130011c01417</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>15-glomerulonefritt-del-1</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5DmQfufYAxnyCl9UJD2T8BP35w4oldYHdOJ1mE+W4yENEuyuxENDDtNzC014bRQVB/dZpjfGQww8Fbi8GU3Bq7j]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>15</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1676924321724-f6fb6d1b3093c6a0e21fa4f69d24a17f.jpeg"/>
			<description><![CDATA[<p><strong>NB!</strong> Hvis illustrasjonen av glomeruli ikke vises (f.eks. i Apple podcast): <a href="https://shows.acast.com/revmatologi/episodes/15-glomerulonefritt-del-1" rel="noopener noreferrer" target="_blank">trykk her for å se den</a>.</p><br><p>Oversiktsepisode om glomerulonefritt fra et revmatologiperspektiv. Gjest: Egil Riveland, konstituert overlege ved Kardiologisk avdeling, Stavanger universitetssjukehus.</p><br><p>Temaer som dekkes: glomerulopati versus glomerulonefritt, proteinuri (glomerulær, tubulær, overflow), hematuri (glomerulær, postglomerulær), nefrittisk versus nefrotisk syndrom, immunologiske mekanismer ved glomerulonefritt, histologifunn (lysmikroskopi, immunfluorescens og elektronmikroskopi).</p><br><p>Første sesong av podcasten er finansiert gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p><strong>NB!</strong> Hvis illustrasjonen av glomeruli ikke vises (f.eks. i Apple podcast): <a href="https://shows.acast.com/revmatologi/episodes/15-glomerulonefritt-del-1" rel="noopener noreferrer" target="_blank">trykk her for å se den</a>.</p><br><p>Oversiktsepisode om glomerulonefritt fra et revmatologiperspektiv. Gjest: Egil Riveland, konstituert overlege ved Kardiologisk avdeling, Stavanger universitetssjukehus.</p><br><p>Temaer som dekkes: glomerulopati versus glomerulonefritt, proteinuri (glomerulær, tubulær, overflow), hematuri (glomerulær, postglomerulær), nefrittisk versus nefrotisk syndrom, immunologiske mekanismer ved glomerulonefritt, histologifunn (lysmikroskopi, immunfluorescens og elektronmikroskopi).</p><br><p>Første sesong av podcasten er finansiert gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Kjempecellearteritt: terminologi</title>
			<itunes:title>Kjempecellearteritt: terminologi</itunes:title>
			<pubDate>Thu, 26 Jan 2023 11:20:28 GMT</pubDate>
			<itunes:duration>13:34</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/63d164c66887790011581bc3/media.mp3" length="19451762" type="audio/mpeg"/>
			<guid isPermaLink="false">63d164c66887790011581bc3</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/14-bonus-kjempecellearteritt-terminologi</link>
			<acast:episodeId>63d164c66887790011581bc3</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>14-bonus-kjempecellearteritt-terminologi</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5Bra0DaRwYD0pAjxZ6HEm3nDpOBMIvp7zHn2OmTIyR1d6RE3lYd/xuA7mahQfZU9WS1oFoeHaDww9YRqa+MojMZ]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>14</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1666189581862-5d71f840859a886c4750316fe150711f.jpeg"/>
			<description><![CDATA[Bonusepisode for de som (i likhet med Jens) liker å gruble over terminologi. Hva skal vi kalle fenotypene av kjempecellearteritt? Kranial, intrakranial, storkar og blandet? Kranial, intrakranial, ekstrakranial og blandet? Eller kranial, intrakranial, ikke-kranial og blandet?<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[Bonusepisode for de som (i likhet med Jens) liker å gruble over terminologi. Hva skal vi kalle fenotypene av kjempecellearteritt? Kranial, intrakranial, storkar og blandet? Kranial, intrakranial, ekstrakranial og blandet? Eller kranial, intrakranial, ikke-kranial og blandet?<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Myositt del 3: ekspertepisode med Helena Andersson</title>
			<itunes:title>Myositt del 3: ekspertepisode med Helena Andersson</itunes:title>
			<pubDate>Fri, 06 Jan 2023 11:15:41 GMT</pubDate>
			<itunes:duration>1:37:09</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/63b802de08aab500119e08b8/media.mp3" length="139214376" type="audio/mpeg"/>
			<guid isPermaLink="false">63b802de08aab500119e08b8</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/13-myositt-del-3-ekspertepisode-med-helena-andersson</link>
			<acast:episodeId>63b802de08aab500119e08b8</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>13-myositt-del-3-ekspertepisode-med-helena-andersson</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5CJmz1ail6mHfwMOivNeWMOmB1kz4LjC5n/jGSDJ6PgnqCtiCO4pjmBNzVuXCi2nfol0q8H+1xVzWWoaWFJaAcL]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>13</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1666189581862-5d71f840859a886c4750316fe150711f.jpeg"/>
			<description><![CDATA[<p>Ekspertepisode. Gjest: Helena Andersson, overlege og seksjonsleder ved Seksjon for Revmatologi, Rikshospitalet.</p><br><p><a href="https://metodebok.no/index.php?action=topic&amp;item=CjVQ64QL" rel="noopener noreferrer" target="_blank">Nasjonal prosedyre om idiopatisk inflammatorisk myopati fra Norsk revmatologisk forening</a></p><br><p>(Første sesong av podcasten er finansiert av Norsk revmatologisk forening)</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Ekspertepisode. Gjest: Helena Andersson, overlege og seksjonsleder ved Seksjon for Revmatologi, Rikshospitalet.</p><br><p><a href="https://metodebok.no/index.php?action=topic&amp;item=CjVQ64QL" rel="noopener noreferrer" target="_blank">Nasjonal prosedyre om idiopatisk inflammatorisk myopati fra Norsk revmatologisk forening</a></p><br><p>(Første sesong av podcasten er finansiert av Norsk revmatologisk forening)</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>IgG4-relatert sykdom del 3: diagnostikk og behandling</title>
			<itunes:title>IgG4-relatert sykdom del 3: diagnostikk og behandling</itunes:title>
			<pubDate>Sun, 18 Dec 2022 15:21:00 GMT</pubDate>
			<itunes:duration>49:39</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/63921fee126d5c0010102f66/media.mp3" length="71162849" type="audio/mpeg"/>
			<guid isPermaLink="false">63921fee126d5c0010102f66</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/12-igg4-relatert-sykdom-del-3-diagnostikk-og-behandling</link>
			<acast:episodeId>63921fee126d5c0010102f66</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>12-igg4-relatert-sykdom-del-3-diagnostikk-og-behandling</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5C+f8krhOzy7g/NWEa6RkTEpwifT+5D2WBdu3RKo37LV/wtrqiLKKK+6VOGP2XicsYIWdLigg8IQ5g1tFBvTuk8]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>12</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1666189581862-5d71f840859a886c4750316fe150711f.jpeg"/>
			<description><![CDATA[<p>Oversiktsepisode. Gjest: Jon Aambakk, konstitutert overlege ved ØNH-avdelingen, Stavanger universitetssjukehus.</p><br><p><a href="https://metodebok.no/index.php?action=topic&amp;item=7zZhbqYX" rel="noopener noreferrer" target="_blank">Prosedyre for IgG4-relatert sykdom (norskrevmatologi.no)</a>.</p><br><p>Første sesong av podcasten er finansiert av Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Oversiktsepisode. Gjest: Jon Aambakk, konstitutert overlege ved ØNH-avdelingen, Stavanger universitetssjukehus.</p><br><p><a href="https://metodebok.no/index.php?action=topic&amp;item=7zZhbqYX" rel="noopener noreferrer" target="_blank">Prosedyre for IgG4-relatert sykdom (norskrevmatologi.no)</a>.</p><br><p>Første sesong av podcasten er finansiert av Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>IgG4-relatert sykdom del 2: klinikk</title>
			<itunes:title>IgG4-relatert sykdom del 2: klinikk</itunes:title>
			<pubDate>Thu, 08 Dec 2022 21:02:24 GMT</pubDate>
			<itunes:duration>36:19</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/63921fc204f1e60011f8c2c0/media.mp3" length="52046311" type="audio/mpeg"/>
			<guid isPermaLink="false">63921fc204f1e60011f8c2c0</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/11-igg4-relatert-sykdom-del-2-klinikk</link>
			<acast:episodeId>63921fc204f1e60011f8c2c0</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>11-igg4-relatert-sykdom-del-2-klinikk</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5A7T8+hLmbFY2ylVCUlnf4oGpEif3nQ/36z1DlyRo/xgfCbD2a/S4y4GwrQRsZXtbvEgCSG8Z5rGZQhb9BrYC45]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>11</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1666189581862-5d71f840859a886c4750316fe150711f.jpeg"/>
			<description><![CDATA[<p>Oversiktsepisode. Gjest: Jon Aambakk, konstitutert overlege ved ØNH-avdelingen, Stavanger universitetssjukehus.</p><br><p><a href="https://metodebok.no/index.php?action=topic&amp;item=7zZhbqYX" rel="noopener noreferrer" target="_blank">Prosedyre for IgG4-relatert sykdom (norskrevmatologi.no)</a>.</p><br><p>(Første sesong er finansiert av Norsk revmatologisk forening)</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Oversiktsepisode. Gjest: Jon Aambakk, konstitutert overlege ved ØNH-avdelingen, Stavanger universitetssjukehus.</p><br><p><a href="https://metodebok.no/index.php?action=topic&amp;item=7zZhbqYX" rel="noopener noreferrer" target="_blank">Prosedyre for IgG4-relatert sykdom (norskrevmatologi.no)</a>.</p><br><p>(Første sesong er finansiert av Norsk revmatologisk forening)</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>IgG4-relatert sykdom del 1: historikk og konsept</title>
			<itunes:title>IgG4-relatert sykdom del 1: historikk og konsept</itunes:title>
			<pubDate>Thu, 08 Dec 2022 21:01:58 GMT</pubDate>
			<itunes:duration>32:34</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/63921f21d296110011ca4704/media.mp3" length="46668871" type="audio/mpeg"/>
			<guid isPermaLink="false">63921f21d296110011ca4704</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/10-igg4-relatert-sykdom-del-1-historikk-og-konsept</link>
			<acast:episodeId>63921f21d296110011ca4704</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>10-igg4-relatert-sykdom-del-1-historikk-og-konsept</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5D8DSLttsXKWahzItvEsz4zwXd0+vBdTpRcIKDh4RaRp9Fg/1G5234O0dUU5os3Pi24/rKO3QnAJfw0ghG/2vcQ]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>10</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1666189581862-5d71f840859a886c4750316fe150711f.jpeg"/>
			<description><![CDATA[<p>Oversiktsepisode. Gjest: Jon Aambakk, konstituert overlege ved ØNH-avdelingen, Stavanger universitetssjukehus.</p><br><p>(Første sesong av podcasten er finansiert av Norsk revmatologisk forening).</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Oversiktsepisode. Gjest: Jon Aambakk, konstituert overlege ved ØNH-avdelingen, Stavanger universitetssjukehus.</p><br><p>(Første sesong av podcasten er finansiert av Norsk revmatologisk forening).</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Myositt del 2c: immunmediert nekrotiserende myopati</title>
			<itunes:title>Myositt del 2c: immunmediert nekrotiserende myopati</itunes:title>
			<pubDate>Wed, 30 Nov 2022 13:27:34 GMT</pubDate>
			<itunes:duration>18:10</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/63866b70d795790011e5fc8f/media.mp3" length="26038493" type="audio/mpeg"/>
			<guid isPermaLink="false">63866b70d795790011e5fc8f</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/9-myositt-del-2c-immunmediert-nekrotiserende-myopati</link>
			<acast:episodeId>63866b70d795790011e5fc8f</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>9-myositt-del-2c-immunmediert-nekrotiserende-myopati</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5BGPaCdJAYGESmJYSpWOrmmkdWwg8L29IZU67RPJVYaBh62taihmXH2mZzxil+HW34qO4p8VUiqGwwKfPKY0vIC]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>9</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1666189581862-5d71f840859a886c4750316fe150711f.jpeg"/>
			<description><![CDATA[<p>Oversiktsepisode. Myositt del 2a: immunmediert nekrotiserende myopati. Gjest: Marte Sæverås, lungelege og seksjonsoverlege ved Diagnostisk senter, Stavanger universitetssjukehus.</p><br><p>Autoantistoff omtalt i episoden: anti-SRP, anti-HMG CoA reduktase (anti-HMGCR)</p><br><p>Abstract om <a href="https://acrabstracts.org/abstract/cancer-screening-recommendations-for-patients-with-idiopathic-inflammatory-myopathy/?fbclid=IwAR0wdASD4SZ2F54QRy44N7_GOfHEMacOl4GQFzVZ-73sAUyuq9ijFu2Xi9M" rel="noopener noreferrer" target="_blank">internasjonale anbefalinger for malignitetsscreening ved idiopatisk inflammatorisk myopati</a>.</p><br><p>(Første sesong av podcasten er finansiert av Norsk revmatologisk forening)</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Oversiktsepisode. Myositt del 2a: immunmediert nekrotiserende myopati. Gjest: Marte Sæverås, lungelege og seksjonsoverlege ved Diagnostisk senter, Stavanger universitetssjukehus.</p><br><p>Autoantistoff omtalt i episoden: anti-SRP, anti-HMG CoA reduktase (anti-HMGCR)</p><br><p>Abstract om <a href="https://acrabstracts.org/abstract/cancer-screening-recommendations-for-patients-with-idiopathic-inflammatory-myopathy/?fbclid=IwAR0wdASD4SZ2F54QRy44N7_GOfHEMacOl4GQFzVZ-73sAUyuq9ijFu2Xi9M" rel="noopener noreferrer" target="_blank">internasjonale anbefalinger for malignitetsscreening ved idiopatisk inflammatorisk myopati</a>.</p><br><p>(Første sesong av podcasten er finansiert av Norsk revmatologisk forening)</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Myositt del 2b: antisyntetasesyndrom</title>
			<itunes:title>Myositt del 2b: antisyntetasesyndrom</itunes:title>
			<pubDate>Wed, 30 Nov 2022 13:27:23 GMT</pubDate>
			<itunes:duration>14:17</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/63866b35ba08230010caa447/media.mp3" length="20479272" type="audio/mpeg"/>
			<guid isPermaLink="false">63866b35ba08230010caa447</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/8-myositt-del-2b-antisyntetasesyndrom</link>
			<acast:episodeId>63866b35ba08230010caa447</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>8-myositt-del-2b-antisyntetasesyndrom</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5BYr7FU6pzVc7UgaA6ZxorQUu5He61qwXYW9fnZz8RGXIQj5fdLBgcBhQDAGl3xWhnhpeb5dpZEINDxOdzq8LW2]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>8</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1666189581862-5d71f840859a886c4750316fe150711f.jpeg"/>
			<description><![CDATA[<p>Oversiktsepisode. Myositt del 2a: antisyntetasesyndrom. Gjest: Marte Sæverås, lungelege og seksjonsoverlege ved Diagnostisk senter, Stavanger universitetssjukehus.</p><br><p>Autoantistoff omtalt i episoden: anti-Jo1, anti-PL7, anti-PL12, anti-OJ, anti-EJ, anti-KS, anti-Zo, anti-Ha</p><br><p>Abstract om <a href="https://acrabstracts.org/abstract/cancer-screening-recommendations-for-patients-with-idiopathic-inflammatory-myopathy/?fbclid=IwAR0wdASD4SZ2F54QRy44N7_GOfHEMacOl4GQFzVZ-73sAUyuq9ijFu2Xi9M" rel="noopener noreferrer" target="_blank">internasjonale anbefalinger for malignitetsscreening ved idiopatisk inflammatorisk myopati</a>.</p><br><p>(Første sesong av podcasten er finansiert av Norsk revmatologisk forening)</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Oversiktsepisode. Myositt del 2a: antisyntetasesyndrom. Gjest: Marte Sæverås, lungelege og seksjonsoverlege ved Diagnostisk senter, Stavanger universitetssjukehus.</p><br><p>Autoantistoff omtalt i episoden: anti-Jo1, anti-PL7, anti-PL12, anti-OJ, anti-EJ, anti-KS, anti-Zo, anti-Ha</p><br><p>Abstract om <a href="https://acrabstracts.org/abstract/cancer-screening-recommendations-for-patients-with-idiopathic-inflammatory-myopathy/?fbclid=IwAR0wdASD4SZ2F54QRy44N7_GOfHEMacOl4GQFzVZ-73sAUyuq9ijFu2Xi9M" rel="noopener noreferrer" target="_blank">internasjonale anbefalinger for malignitetsscreening ved idiopatisk inflammatorisk myopati</a>.</p><br><p>(Første sesong av podcasten er finansiert av Norsk revmatologisk forening)</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Myositt del 2a: dermatomyositt</title>
			<itunes:title>Myositt del 2a: dermatomyositt</itunes:title>
			<pubDate>Wed, 30 Nov 2022 13:27:07 GMT</pubDate>
			<itunes:duration>24:56</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/63866acdff7670001107dc73/media.mp3" length="35726886" type="audio/mpeg"/>
			<guid isPermaLink="false">63866acdff7670001107dc73</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/7-myositt-del-2a-dermatomyositt</link>
			<acast:episodeId>63866acdff7670001107dc73</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>7-myositt-del-2a-dermatomyositt</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5D+RTcI55oArY1xrQWiOK8WfaJuSZTwtRuLr6Gy5bzEu73i5L0YBNrwWJaIOg1mDV28T9Mn1ZtEWKUWxo2gyl0q]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>7</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1666189581862-5d71f840859a886c4750316fe150711f.jpeg"/>
			<description><![CDATA[<p>Oversiktsepisode. Myositt del 2a: dermatomyositt. Gjest: Marte Sæverås, lungelege og seksjonsoverlege ved Diagnostisk senter, Stavanger universitetssjukehus.</p><br><p>Autoantistoff omtalt i episoden: anti-Mi2, anti-SAE, anti-NXP2, anti-TIF1, anti-MDA5.</p><br><p>Abstract om <a href="https://acrabstracts.org/abstract/cancer-screening-recommendations-for-patients-with-idiopathic-inflammatory-myopathy/?fbclid=IwAR0wdASD4SZ2F54QRy44N7_GOfHEMacOl4GQFzVZ-73sAUyuq9ijFu2Xi9M" rel="noopener noreferrer" target="_blank">internasjonale anbefalinger for malignitetsscreening ved idiopatisk inflammatorisk myopati</a>.</p><br><p>ProDERM-studien om <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2117912" rel="noopener noreferrer" target="_blank">intravenøse immunglobuliner ved dermatomyositt</a>.</p><br><p>(Første sesong av podcasten er finansiert av Norsk revmatologisk forening)</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Oversiktsepisode. Myositt del 2a: dermatomyositt. Gjest: Marte Sæverås, lungelege og seksjonsoverlege ved Diagnostisk senter, Stavanger universitetssjukehus.</p><br><p>Autoantistoff omtalt i episoden: anti-Mi2, anti-SAE, anti-NXP2, anti-TIF1, anti-MDA5.</p><br><p>Abstract om <a href="https://acrabstracts.org/abstract/cancer-screening-recommendations-for-patients-with-idiopathic-inflammatory-myopathy/?fbclid=IwAR0wdASD4SZ2F54QRy44N7_GOfHEMacOl4GQFzVZ-73sAUyuq9ijFu2Xi9M" rel="noopener noreferrer" target="_blank">internasjonale anbefalinger for malignitetsscreening ved idiopatisk inflammatorisk myopati</a>.</p><br><p>ProDERM-studien om <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2117912" rel="noopener noreferrer" target="_blank">intravenøse immunglobuliner ved dermatomyositt</a>.</p><br><p>(Første sesong av podcasten er finansiert av Norsk revmatologisk forening)</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Serum urinsyre under urinsyregiktanfall</title>
			<itunes:title>Serum urinsyre under urinsyregiktanfall</itunes:title>
			<pubDate>Sat, 19 Nov 2022 11:33:01 GMT</pubDate>
			<itunes:duration>5:12</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/6378beee325c810010a0af1a/media.mp3" length="7459018" type="audio/mpeg"/>
			<guid isPermaLink="false">6378beee325c810010a0af1a</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/6-bonus-urinsyre-under-anfall</link>
			<acast:episodeId>6378beee325c810010a0af1a</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>6-bonus-urinsyre-under-anfall</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5DX+Z0gopahjba0YMAYT3LG343To189uh7qlZwrjIPGjPoqQh4P0Tg/xa3mu1ZUf88fvRcZqnC18JmoAqWJu38s]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>6</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1666189581862-5d71f840859a886c4750316fe150711f.jpeg"/>
			<description><![CDATA[<p>Bonusepisode: hvorfor faller serum urinsyre under et anfall med urinsyregikt?</p><br><p>Lenke til omtalt artikkel: <a href="https://pubmed.ncbi.nlm.nih.gov/12233891/" rel="noopener noreferrer" target="_blank">Urano W et al. 2002</a>.</p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Bonusepisode: hvorfor faller serum urinsyre under et anfall med urinsyregikt?</p><br><p>Lenke til omtalt artikkel: <a href="https://pubmed.ncbi.nlm.nih.gov/12233891/" rel="noopener noreferrer" target="_blank">Urano W et al. 2002</a>.</p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Myositt del 1: en oversikt</title>
			<itunes:title>Myositt del 1: en oversikt</itunes:title>
			<pubDate>Thu, 27 Oct 2022 13:51:15 GMT</pubDate>
			<itunes:duration>54:21</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/635a73f1d9059b0011aada8d/media.mp3" length="77886136" type="audio/mpeg"/>
			<guid isPermaLink="false">635a73f1d9059b0011aada8d</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/5-myositt-del-1-en-oversikt</link>
			<acast:episodeId>635a73f1d9059b0011aada8d</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>5-myositt-del-1-en-oversikt</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5D/ZnIjcjluTJkn93dJPAlyB53/qrwLNil/GSW+XDjZjTlee3shdjRCXcPOebwazeACnCJxoRMwePQhitLoo+qe]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>5</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1666189581862-5d71f840859a886c4750316fe150711f.jpeg"/>
			<description><![CDATA[<p>Oversiktsepisode. Idiopatisk inflammatorisk myopati (IIM, også kalt "myositt") del 1: Jens snakker generelt om IIM. Gjest: Marte Sæverås, lungelege og seksjonsoverlege ved Diagnostisk senter, Stavanger universitetssjukehus.</p><br><p>Dette er en trilogi om IIM: I denne episoden presenteres undergrupper (som polymyositt (PM), dermatomyositt (DM), antisyntetasesyndrom (ASS) og immunmediert nekrotiserende myopati (IMNM)), samt overordnet informasjon om manifestasjoner og utredning (herunder myosittspesifikke autoantistoffer (MSA)). I neste episode går vi mer i detalj av de ulike undertypene. I siste episode (ekspertepisode) snakker vi om tips og triks om utredning og behandling av IIM</p><br><p>Begreper som nevnes i episoden: (1) Utslett ved DM: heliotropt utslett, Gottronske papler, Gottrons tegn, V-tegn, sjaltegn, hylstertegn; (2) Hudforandring ved ASS: mekanikerhender; (3) MSA forbundet med DM: anti-Mi2, anti-SAE, anti-NXP2, anti-TIF1, anti-MDA5; (4) MSA forbundet med ASS: "antisyntetaseantistoffer" (anti-Jo1, anti-PL7, anti-PL12, og noen flere (OJ, EJ, KS, Zo, YRS)); (5) MSA forbundet med IMNM: anti-HMG CoA reduktase, anti-SRP.</p><br><p>Første sesong av podcasten er finansiert gjennom et stipend av Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Oversiktsepisode. Idiopatisk inflammatorisk myopati (IIM, også kalt "myositt") del 1: Jens snakker generelt om IIM. Gjest: Marte Sæverås, lungelege og seksjonsoverlege ved Diagnostisk senter, Stavanger universitetssjukehus.</p><br><p>Dette er en trilogi om IIM: I denne episoden presenteres undergrupper (som polymyositt (PM), dermatomyositt (DM), antisyntetasesyndrom (ASS) og immunmediert nekrotiserende myopati (IMNM)), samt overordnet informasjon om manifestasjoner og utredning (herunder myosittspesifikke autoantistoffer (MSA)). I neste episode går vi mer i detalj av de ulike undertypene. I siste episode (ekspertepisode) snakker vi om tips og triks om utredning og behandling av IIM</p><br><p>Begreper som nevnes i episoden: (1) Utslett ved DM: heliotropt utslett, Gottronske papler, Gottrons tegn, V-tegn, sjaltegn, hylstertegn; (2) Hudforandring ved ASS: mekanikerhender; (3) MSA forbundet med DM: anti-Mi2, anti-SAE, anti-NXP2, anti-TIF1, anti-MDA5; (4) MSA forbundet med ASS: "antisyntetaseantistoffer" (anti-Jo1, anti-PL7, anti-PL12, og noen flere (OJ, EJ, KS, Zo, YRS)); (5) MSA forbundet med IMNM: anti-HMG CoA reduktase, anti-SRP.</p><br><p>Første sesong av podcasten er finansiert gjennom et stipend av Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Immunologi del 3: autoinflammasjon</title>
			<itunes:title>Immunologi del 3: autoinflammasjon</itunes:title>
			<pubDate>Tue, 18 Oct 2022 16:42:59 GMT</pubDate>
			<itunes:duration>41:07</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/63485e936227d70013918536/media.mp3" length="58921815" type="audio/mpeg"/>
			<guid isPermaLink="false">63485e936227d70013918536</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/immunologi-del-3-autoinflammasjon</link>
			<acast:episodeId>63485e936227d70013918536</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>immunologi-del-3-autoinflammasjon</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5B4VahJu32gheS9rJbX97RxB1xj5lSy+VVxfAOflE6/t1EJLqxEOlToCBq+tlQmSoJ1QlCH728XD1vMS8x1ZI7b]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>4</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1666189807219-6ea9546647afcee92c69ae0221564f89.jpeg"/>
			<description><![CDATA[<p>Oversiktsepisode. Del 3 av immunologi ved revmatologisk sykdom. Gjest: Maren Svensen, LIS i indremedisin.</p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Oversiktsepisode. Del 3 av immunologi ved revmatologisk sykdom. Gjest: Maren Svensen, LIS i indremedisin.</p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Immunologi del 2: autoimmunitet</title>
			<itunes:title>Immunologi del 2: autoimmunitet</itunes:title>
			<pubDate>Tue, 18 Oct 2022 16:42:41 GMT</pubDate>
			<itunes:duration>19:13</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/63485e20a4b25300117de44e/media.mp3" length="27548252" type="audio/mpeg"/>
			<guid isPermaLink="false">63485e20a4b25300117de44e</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/immunologi-del-2-autoimmunitet</link>
			<acast:episodeId>63485e20a4b25300117de44e</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>immunologi-del-2-autoimmunitet</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5CTlyS0SmasFtu12jzbL7dN82qWolu1SLjP/IGJhja9RDZ5SIKztQ6ZaOIWIHoa575I4uIqKJ27Fu96iqFv+glT]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>3</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1666190001292-6490cf99b2633a1ead458b3aebe9f63b.jpeg"/>
			<description><![CDATA[<p>Oversiktsepisode. Del 2 av immunologi ved revmatologisk sykdom. Gjest: Maren Svensen, LIS i indremedisin.</p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Oversiktsepisode. Del 2 av immunologi ved revmatologisk sykdom. Gjest: Maren Svensen, LIS i indremedisin.</p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Immunologi del 1: immunologisk toleranse</title>
			<itunes:title>Immunologi del 1: immunologisk toleranse</itunes:title>
			<pubDate>Tue, 18 Oct 2022 16:35:47 GMT</pubDate>
			<itunes:duration>36:29</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/6341d0264240260013dd4ca3/media.mp3" length="52275101" type="audio/mpeg"/>
			<guid isPermaLink="false">6341d0264240260013dd4ca3</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/o-immunologisk-toleranse</link>
			<acast:episodeId>6341d0264240260013dd4ca3</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>o-immunologisk-toleranse</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5CkLD2Wg+AKDVEeWqqZEBrMWxkKGtCqRC53p4RrbIxreMVl00l9myE3m11nkf46TakUcLc+tmPW1LydLeC3eTdY]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>2</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1666189961589-b6565da1f50cb13c8d963498e3898097.jpeg"/>
			<description><![CDATA[<p>Oversiktsepisode. Del 1 om immunologi ved revmatologisk sykdom. Gjest: Maren Svensen, LIS i indremedisin.</p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Oversiktsepisode. Del 1 om immunologi ved revmatologisk sykdom. Gjest: Maren Svensen, LIS i indremedisin.</p><br><p>Første sesong av podcasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Introduksjon</title>
			<itunes:title>Introduksjon</itunes:title>
			<pubDate>Tue, 18 Oct 2022 07:16:59 GMT</pubDate>
			<itunes:duration>2:48</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/630e07bea839d60014dfb735/e/634bf964a8cdf400125db85c/media.mp3" length="4028882" type="audio/mpeg"/>
			<guid isPermaLink="false">634bf964a8cdf400125db85c</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/revmatologi/episodes/introduksjon</link>
			<acast:episodeId>634bf964a8cdf400125db85c</acast:episodeId>
			<acast:showId>630e07bea839d60014dfb735</acast:showId>
			<acast:episodeUrl>introduksjon</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zs1qGNKzkZqIR5ZRXWHwoBZyPxDY22/frs5LRWc9CEo5Csd8o8XT+nMxeFU/8Ri2kmcQas8zLWF+jc56TfQfFV3gpHBARwxU1jgCqoNjVWOCzrGct7bpvpbSfa6nTT11lg]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>1</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/630e07bea839d60014dfb735/1666189921176-d47dddf21b7d7dab18868390809e70a3.jpeg"/>
			<description><![CDATA[<p>Velkommen til "Revmatologi", en pocast for leger og medisinstudenter. Av og med Jens Vikse, LIS i revmatologi.</p><br><p>Podcasten er tilleggsmateriale til en kommende norsk lærebok i revmatologi. Første sesong av podcasten er finansiert gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Velkommen til "Revmatologi", en pocast for leger og medisinstudenter. Av og med Jens Vikse, LIS i revmatologi.</p><br><p>Podcasten er tilleggsmateriale til en kommende norsk lærebok i revmatologi. Første sesong av podcasten er finansiert gjennom et stipend fra Norsk revmatologisk forening.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<itunes:category text="Health &amp; Fitness">
			<itunes:category text="Medicine"/>
		</itunes:category>
    </channel>
</rss>
